FISHKILL, NY–(Marketwire – July 22, 2010) –  Nano Mask, Inc. (PINKSHEETS: NANM) today announced that it has entered into a manufacturing agreement with a well established Canadian company that will produce Nano Mask’s own proprietarily labeled multi amino acid enzyme cleaning products for the International and United States hospital markets. Nano Mask launched the distribution of this product suite on July 13, 2010 through a network of distributors and manufacturers’ representatives in the United States and internationally.

The Canadian manufacturer has developed a full line of enzyme based and chemical based medical specialty detergents for the demanding cleaning of medical instruments, laboratory glassware, endoscopes and hospital carts. These specialty detergents have become the preferred Multi-Enzyme Based Hospital instrument Pre-Soak and Cleaning Solution in the Canadian hospital market. Nano Mask’s initial products include:

• Nano-Zyme, a Multi Enzyme Based Hospital Instrument Pre-Soak and Cleaning Solution that is a non foaming formulation that does not cause eye, nose, throat, skin or lung irritation as do the current products being used today.

• Nano-Zyme Ortho Plus, a one step pre-soak enzymatic cleaning product specifically designed to emulsify and remove stubborn fats, oils, blood tissue, bone grease and lubricants on Orthopedic and Arthroscopic Instruments.

• Nano-Med Care, a Multi Enzyme Based Pre Clean enzyme gel formulated as a transport gel to initiate the cleaning process at point of use in operating rooms, endoscopy suites, labs and central processing areas.

• Nano-Odor Away, a Clear, Natural and Non Toxic liquid that eliminates odors from colostomy appliances and irrigation units, use of which eliminates the need to use masking agents and caustic chemicals.

“We are excited to launch this line of new green products for the hospital market in the U.S. and internationally,” said Edward J. Suydam, President and CEO, Nano Mask. “The reception from our distributors has been very strong and we expect to broaden our distribution capabilities — especially in international markets — over the coming months.”

Mr. Suydam added, “We entered this venture in an effort to create another source of revenues to complement the orders that we have generated from our distribution of Wein respirators while we continue to work on the completion of our own, proprietary NanoMask™ respirator.”

Separately, the company announced that it was continuing to make progress in bringing its S.E.C. filings up to date.

About Nano Mask, Inc.

http://nanomaskinc.com/

Nano Mask, Inc. is the inventor of the NanoMask, a disposable anti-microbial facemask currently under development and is a distributor of Wein Products’ line of disposable respirators and the new line of hospital detergent products.
Forward-looking Statement

This release may contain statements that are forward-looking. Such statements are made based upon current expectations that are subject to risk and uncertainty. Specifically, any unforeseen delays in distribution may affect the planned timeline for initiating actual sales of the product. NMI does not undertake to update forward-looking statements in this news release to reflect actual results of and changes in assumptions or changes in other factors affecting such forward-looking information. The actual future plans and results of the company could differ significantly from such forward-looking statements.

SOPHIA ANTIPOLIS, FRANCE–(Marketwire – July 22, 2010) – www.nicox.com

NicOx S.A. (NYSE Euronext Paris: COX) today announced the receipt of a
Complete Response Letter from the U.S. Food and Drug Administration (FDA)
related to the New Drug Application (NDA) for naproxcinod. Naproxcinod is
being developed for the relief of the signs and symptoms of osteoarthritis.

The FDA informed NicOx that its review of the NDA is complete and that it
does not approve the naproxcinod application. The FDA has recommended
conducting one or more long-term controlled studies to assess the
cardiovascular and gastrointestinal safety of naproxcinod. Additional
studies to demonstrate a clinically meaningful therapeutic benefit
attributable to the nitric oxide donation were also recommended. No
clinical efficacy studies were requested.

NicOx plans to discuss the Complete Response Letter and potential next
steps as early as possible with the FDA.

The naproxcinod Marketing Authorization Application (MAA) submitted by
NicOx in December 2009 is currently under review by the European Medicines
Agency (EMA).

NicOx remains well funded and had cash, cash equivalents and financial
instruments of ?138.5 million at the end of March 2010. The Company
will publish its financial results for the first half of 2010 on July 30,
2010. NicOx has no long-term debt and is constantly reviewing all aspects
of its cost base to ensure careful conservation of its funds.

NicOx has a broad pipeline of nitric oxide (NO)-donating New Molecular
Entities (NMEs) targeting the therapeutic areas of inflammatory,
cardiometabolic and ophthalmological diseases. NicOx has built a network of
strong partnerships for the development of some of its promising lead
compounds, including alliances with Merck & Co., Inc., Bausch + Lomb and
Ferrer.

Risks factors which are likely to have a material effect on NicOx’s
business are presented in the 4th chapter of the ” Document de
référence, rapport financier annuel et rapport de gestion 2009 ”
filed with the French Autorité des Marchés Financiers (AMF) on
March 5, 2010 and available on NicOx’s website (www.nicox.com) and on the
AMF’s website
(www.amf-france.org).

The Company notably draws the investors’ attention to the following risk
factors:

– Risques liés à la dépendance de la Société
à l’égard du naproxcinod (Risks related to the Company’s
dependence on the success of its lead product naproxcinod)

– Risques commerciaux et développements cliniques (Clinical
developments and commercial risk)

– Risques liés aux contraintes réglementaires et à la
lenteur des procédures d’approbation (Risks linked to regulatory
constraints and slow approval procedures)

– Manque de capacités dans les domaines de la vente et du marketing
(Lack of sales and marketing capabilities)

– Incertitude relative aux prix des médicaments et aux régimes de
remboursement, ainsi qu’en matière de réforme des régimes
d’assurance maladie (Uncertainty on drug pricing and reimbursement policies
and on the reforms of the health insurance systems)

NicOx (Bloomberg: COX:FP, Reuters: NCOX.PA) is a pharmaceutical company
focused on the research, development and future commercialization of drug
candidates. NicOx is applying its proprietary nitric oxide-donating R&D
platform to develop an internal portfolio of New Molecular Entities (NME)
for the potential treatment of inflammatory, cardio-metabolic and
ophthalmological diseases.

NicOx’s lead investigational compound is naproxcinod, an NME and a first-
in-class CINOD (Cyclooxygenase-Inhibiting Nitric Oxide-Donating) anti-
inflammatory drug candidate developed for the relief of the signs and
symptoms of osteoarthritis (OA). In July 2010, the FDA provided a Complete
Response Letter to the New Drug Application (NDA) for naproxcinod stating
that it does not approve the naproxcinod application. The naproxcinod
Marketing Authorization Application (MAA) submitted by NicOx in December
2009 is currently under review by the European Medicines Agency (EMA).

In addition to naproxcinod, NicOx’s pipeline includes several nitric oxide-
donating NMEs, which are in development internally and with partners,
including Merck & Co., Inc. and Bausch + Lomb, for the treatment of
hypertension, cardiometabolic diseases, eye diseases and dermatological
diseases.

NicOx S.A. is headquartered in France and is listed on Euronext Paris
(Compartment B: Mid Caps).

This press release contains certain forward-looking statements. Although
the Company believes its expectations are based on reasonable assumptions,
these forward-looking statements are subject to numerous risks and
uncertainties, which could cause actual results to differ materially from
those anticipated in the forward-looking statements. For a discussion of
risks and uncertainties which could cause actual results, financial
condition, performance or achievements of NicOx S.A. to differ from those
contained in the forward-looking statements, please refer to the Risk
Factors (“Facteurs de Risque”) section of the Document de Reference filed
with the AMF, which is available on the AMF website
(http://www.amf-france.org) or on NicOx S.A.’s website
(http://www.nicox.com).

CONTACTS

www.nicox.com

NicOx

Gavin Spencer – Vice President Business Development Tel +33 (0)4 97 24 53
00 – [email protected]

Media Relations Financial Dynamics

Europe

Guillaume Granier (France) – Tel: +33 (0)1 47 03 68 10 –
[email protected]

Stéphanie Bia (France) – Tel: +33 (0)1 47 03 68 10 –
[email protected]

Jonathan Birt (UK) – Tel +44 (0)20 7269 7205 – [email protected]

United States

Robert Stanislaro – Tel +1 212 850 5657 – [email protected]

Irma Gomez-Dib – Tel +1 212 850 5761 – [email protected]

NicOx S.A.,

Les Taissounières – Bât HB4 – 1681 route des Dolines – BP313,
06906 Sophia Antipolis cedex, France. Tel. +33 (0)4 97 24 53 00 – Fax +33
(0)4 97 24 53 99

This information is provided by HUGIN

MERIDIAN, ID–(Marketwire – July 21, 2010) –  MWI Veterinary Supply, Inc. (NASDAQ: MWIV) announced today that the Company will release financial results for its fiscal year 2010 third quarter ended June 30, 2010 and update its business outlook for its fiscal year ending September 30, 2010 on Thursday, July 29, 2010. MWI will host a conference call the same day at 11:00 am eastern time to discuss these results and its business outlook.

For calls within the United States you can access the conference call by dialing (877) 638-4561 and international callers can access the conference by dialing (720) 545-0002. Participants will be required to register their name and company affiliation for the conference call. The conference call will also be carried live on the Company’s website at www.mwivet.com. Audio replay will be made available through August 12, 2010 by calling (800) 642-1687 for calls within the United States or (706) 645-9291 for international calls using the passcode 89688546 or by accessing the Company’s website.

About MWI Veterinary Supply, Inc.:
MWI Veterinary Supply, Inc. is a leading distributor of animal health products to veterinarians across the United States and United Kingdom. The products MWI sells include pharmaceuticals, vaccines, parasiticides, diagnostics, capital equipment, supplies, veterinary pet food and nutritional products. The Company markets these products to veterinarians in both the companion animal and production animal markets.

KANSAS CITY, MO–(Marketwire – July 21, 2010) –  The Translational Medicine Alliance Forum will convene October 13-14, 2010 at the Mandarin Oriental in Washington, DC. This year’s Forum will be hosted by three organizations with the common interest of accelerating translational research to the patient.

The Forum brings together leaders from academia, government agencies, and pharmaceutical, biotechnology and venture industries to work toward developing a deeper understanding of effective models to enable and accelerate the progress of translational medicine. Through focused, dynamic sessions and exclusive networking opportunities, attendees have the opportunity to learn about breakthrough approaches and progress on current best practices in translational medicine collaborations.

“Translational medicine holds some of the most promising advancements, and through this Forum, we are able to help facilitate and encourage a steady pathway to success for current and future research,” said Lesa Mitchell, vice president of Advancing Innovation, Ewing Marion Kauffman Foundation. The Kauffman Foundation helped found the Translational Medicine Alliance in 2007.

This Forum will focus on the following topics: regulatory science, lessons from the most experienced translational models, how and why rare disease and pediatric medicine are changing the landscape, transparency and access to data and reverse engineering translational science starting with the patient. 

The 2010 Forum is cosponsored by the Ewing Marion Kauffman Foundation, FasterCures and the Council for American Innovation. Registration for the Forum is now open. Early bird rates are available now through August 16, 2010, with a rate of $595 for corporate and $200 for academic and not-for-profit registrations. Space is limited. To register for the Forum, visit https://www.regonline.com/2010_translational_medicine_alliance_forum or call 866-831-3243.

Translational Medicine Alliance

The TransMed Partnership was formed in March 2007 to tap into the best ideas of thought leaders and develop an integrated strategy to support and advance the most promising technologies. The Alliance was founded by the Kauffman Foundation, Pfizer, Johnson and Johnson, Biogen Idec, FasterCures, Washington University, St. Louis (WUSTL) School of Medicine, BioVentures for Global Health, the Center for Emerging Technologies, BIOCOM, BIOTECanada, and LifeTech Innovations. For more information about the Alliance, please visit www.translationalmedicinealliance.org.

MUNDELEIN, IL–(Marketwire – July 21, 2010) –  A new VHA case study whitepaper released by Medline Industries, Inc. details how the company used observational studies and context-based design to build human factors and social behaviors into its redesigned Foley Catheter Management tray.

The whitepaper, Social Practice and Clinicians’ Meaning of Urinary Catheter Insertions, showed that the redesigned tray significantly influenced the clinician’s ability to provide high quality care by creating a greater focus on providing patient comfort, maintaining sterile technique and decreasing the time of the entire insertion process. The observational study was comprised of three separate three-day observations of clinicians conducting catheterizations in the emergency department, medical/surgical floors and operating rooms at Providence Sacred Heart Medical Center and Children’s Hospital, Spokane, WA.

“Health care manufacturers are often overlooked when clinicians redesign clinical practices. Yet, the design of a product can be key to helping clinicians improve clinical performance and patient education,” said Trent Haywood, MD, JD, Senior Vice President of Clinical Performance and Chief Medical Officer for VHA and lead investigator. “For example, Medline chose to redesign the urinary catheter tray based upon the observational data uncovered in the clinical setting. Such design emphasis shows how manufacturers can be a key partner in quality and safety.” 

The unique partnership between Medline and the VHA research team highlights how industry vendors can partner with healthcare providers to develop a comprehensive system that incorporates proper procedures and social behaviors that are easy to adopt in every day practice.

Medline launched its ERASE CAUTI program, which is based on the same criteria the CDC used in developing their new CAUTI prevention guidelines, last fall. Soon after the tray’s introduction, Medline met with the VHA Clinical Performance team to discuss studying the tray and how it’s used in actual clinical practice. Emphasis was put on understanding the objectives of catheter insertions from the clinician’s perspective, clarifying the actual practice that unfolds and identifying areas where the catheter management system aided the clinician or failed to aid the clinician based upon the clinician’s perspective on the practice.

Findings summarized in a case study whitepaper showed that clinicians preferred the benefits of the single layer tray which did not require steps related to maneuvering and positioning with a two layer tray. They also preferred the change to swab sticks that decreased the number of steps in the prepping and cleansing of the perineum. Clinicians retained the patent-pending patient education card for the patient or placed it in location where the patient might review it — a departure from previously observed behavior where the education was discarded without much attention. Clinicians also used the full-colored photography packaging to better explain the procedure to patients.

“Chief Nursing Officers (CNOs) want to help their staff reduce variability in the procedures that are done so that the potential to make an error decreases,” said Connie Yuska, Medline’s Vice President of Clinical Services and a former CNO. “We redesigned the tray taking into account the interaction between the patient and the clinician and facilitate learning — things that challenge nursing leaders every day.”

The VHA whitepaper, as well as additional information on the ERASE CAUTI program, is available for download on Medline’s website at www.medline.com/erase.

About Medline Industries, Inc. 
Medline, the nation’s largest privately held manufacturer and distributor of healthcare products, manufactures and distributes more than 100,000 products to hospitals, extended-care facilities, surgery centers, home care dealers and agencies. Headquartered in Mundelein, Ill., Medline has more than 900 dedicated sales representatives nationwide to support its broad product line and cost management services.

Over the past five years, Medline has been the fastest-growing distributor of medical and surgical supplies in the U.S., serving as the primary distributor to over 450 major hospitals and healthcare systems. As a leading distributor, Medline offers a comprehensive array of consulting and management services encompassing the supply chain and logistics, utilization and standardization, business tools and enhanced reporting capabilities and on-staff clinicians.

MUNDELEIN, IL–(Marketwire – July 21, 2010) –  Medline Industries Inc., the nation’s largest privately held manufacturer and distributor of healthcare supplies, announced today the signing of a cost management prime vendor agreement with the AROK Purchasing Coalition, a VHA supply network comprised of nearly 50 acute care facilities in Arkansas and Oklahoma. The five-year agreement is anticipated to save AROK an estimated $20-$25 million over the term of the contract.

Medline is expected to generate more than $500 million in medical and surgical product sales from the partnership over the term of the agreement. 

AROK was formed to help VHA member hospitals in Arkansas and Oklahoma increase efficiencies and reduce expenses by aggregating supply and services expenditures. 

As part of the agreement, Medline will provide its broad array of Medline brand medical and surgical products, including surgical procedure trays, patient care products, disposable protective gowns, exam gloves and bandages. Medline will drive cost savings to AROK members by delivering products direct to the healthcare facilities from two of Medline’s distribution centers located in Oklahoma City and Memphis, Tenn.

Medline will also deliver cost savings by reducing distribution fees on other national brand products and product standardization. In addition, Medline will provide enhanced reporting capabilities and offer comprehensive product utilization, education and practical solutions to help the facility control costs and improve patient care. 

About AROK
The AROK Purchasing Coalition is a VHA Supply Network. Twenty-one VHA health care organizations, representing nearly 50 hospitals in Arkansas and Oklahoma officially joined together in June 2008 to increase efficiencies and reduce expenses by aggregating supply and services expenditures. Combined annual supply purchases of the purchasing coalition represent in excess of $600 million. As a limited liability corporation, the AROK Purchasing Coalition is recognized as a single VHA member entity and as a large integrated delivery system by the supplier and distributor community. VHA operates the purchasing coalition at the direction of the members.

About Medline Industries, Inc. 
Medline, the nation’s largest privately held manufacturer and distributor of healthcare products, manufactures and distributes more than 100,000 products to hospitals, extended-care facilities, surgery centers, home care dealers and agencies. Headquartered in Mundelein, Ill., Medline has more than 900 dedicated sales representatives nationwide to support its broad product line and cost management services.

Over the past five years, Medline has been the fastest-growing distributor of medical and surgical supplies in the U.S., serving as the primary distributor to over 450 major hospitals and healthcare systems. As a leading distributor, Medline offers a comprehensive array of consulting and management services encompassing the supply chain and logistics, utilization and standardization, business tools and enhanced reporting capabilities and on-staff clinicians.

Medline has a growing network of 32 distribution centers around the country, as well as an expanding, dedicated transportation fleet with over 200 vehicles in a variety of sizes to fit customers’ specific delivery needs. The fleet is equipped with the latest navigation devices for enhanced order tracking and communication.

About VHA
VHA Inc., based in Irving, Texas, is a national network of not-for-profit health care organizations that work together to drive maximum savings in the supply chain arena, set new levels of clinical performance and identify and implement best practices to improve operational efficiency and clinical outcomes. Formed in 1977, through its 16 regional offices, VHA serves more than 1,400 hospitals and more than 25,500+ non-acute care providers nationwide. VHA was ranked by Modern Healthcare as the 7th best place to work in health care in 2009.

PRINCETON, NJ–(Marketwire – July 21, 2010) – In a recent USA Today article, medical tourism is getting a huge boost from American based employers and insurers who encourage employees to consider domestic medical travel. Therefore, instead of seeking out medical travel or affordable healthcare alternatives overseas such as Thailand or India, employees are being directed to regional facilities that offer high-quality care and lower prices. “The move is reducing healthcare costs by 20% to 40%, with the difference often covering travel expenses,” says David Goldstein, President of Health Options Worldwide (HOW), an online medical tourism company.

“When people hear the words ‘medical tourism,’ they automatically think overseas,” explained Goldstein, “But low-cost healthcare can be found in this country, even if it involves some travel.” Employers who offer domestic medical travel programs can save healthcare money by negotiating a single rate. This rate can include surgical and anesthesia fees and all medical care performed up until discharge.

Large corporations like Lowe’s, the home improvement retailer, already have such programs in place. A self-insured employer, Lowe’s struck a deal with a cardio care clinic where they send their employees for open-heart surgeries, valve repairs and pacemakers. In the future, they may add orthopedic surgeries to their program. Other large employers may soon follow suit with similar agreements with healthcare providers. Some companies provide financial incentives to medical travelers like waived deductions, copayment reductions and paid travel expenses.

“If this concept catches on, especially with large employers, it could help decrease healthcare costs and improve the quality of medical care by creating a competitive marketplace,” says Goldstein. Hospitals dictate costs and affect health insurance premiums. “However, it’s very sobering to see how much medical costs and quality can vary between hospitals and regions,” said Goldstein.

However, the focus should still be on quality along with financial balance, advises Goldstein. “With tempting financial incentives, employees may be forced to choose cost instead of quality, and the choice will be taken out of their hands,” explained Goldstein. Still the savings are hard to beat, especially when there are fewer complications from procedures that are done with high quality providers. Follow-up care, like physical therapy, is done locally and covered under the employee’s regular insurance plan.

Programs like these could spur the domestic healthcare marketplace to respond with even lower costs in order to lure patients to their centers. Insurance companies are hesitant to offer domestic medical travel incentives because it creates ill will with local healthcare providers, who then lower their costs in response. “This is why employers, healthcare providers and insurance companies will have no choice but to embrace this trend,” said Goldstein.

Click here to see all recent news from this company

ROCKVILLE, MD and SEOUL, KOREA–(Marketwire – July 21, 2010) – The emergence and spread of drug-resistant mycobacterium tuberculosis (TB) threatens global TB control efforts, and there is an urgent need for new diagnostic tests that rapidly identify drug sensitivity profiles of TB strains. To help address these concerns, Seegene today introduced Anyplex™ MDR-TB Screening Test, the first real-time PCR molecular diagnostic capable of simultaneous detection of TB and genetic mutations leading to multi-drug resistant TB (MDR-TB) within four hours.

Seegene Anyplex™ MDR-TB Test will be introduced at the 2010 Annual Meeting and Clinical Lab Expo of the American Association for Clinical Chemistry (AACC), booth #1800.

According to the World Health Organization (WHO), TB strains that are resistant to all major anti-TB drugs have been documented in every country by the non-governmental organization recent survey. A particularly dangerous form of drug-resistant TB is multi-drug resistant TB (MDR-TB), which is defined as the disease caused by TB bacilli resistant to, among others, the two most powerful anti-TB drugs, isoniazid (INH) and rifampicin (Rif).The rate for successful MDR-TB treatment is extremely low and the progress of the disease is faster than normal TB, resulting in 40-50% of mortality rate. Rates of MDR-TB are troublingly high in some countries, especially in the former Soviet Union, and threaten TB infectious disease control efforts. WHO estimates that more than 440,000 people are infected with MDR-TB.

Using Anyplex^™ MDR-TB Screening Test, healthcare workers will be able to quickly determine whether or not a patient is infected with a strain of TB that is resistant to INH and Rif. The Anyplex^™ MDR-TB is a real-time detection test of M. tuberculosis that quickly and comprehensively determines the levels of targets in a patient’s various sample types, and identifies mutations of drug resistant genes to better inform a diagnosis.

Because genetic mutations that lead to antibiotic resistance are minute and sit close together, so far conventional PCR or conventional real-time PCR tests are not able to discriminate these mutations accurately within the same test procedure. In contrast, the Anyplex MDR-TB test can detect the mutations of drug resistant genes to Rif (rpoB: D516V/Y, H526D/Y, S531L) and INH (katG: S315T (2 cases); inhA promoter: -15(C/T)). The unprecedented speed and accuracy of the Anyplex MDR-TB Tests will enable doctors and clinicians to quickly provide an appropriate treatment to prevent the spread of MDR-TB.

Seegene’s new MDR-TB test takes TB diagnostics to a new level. Current TB test methods are hindered by speed (culture typically required 2-8 weeks for results), low sensitivity (acid-fast bacilli smear microscopy produced results in 24 hours but at the cost of missing a significant portion of TB cases) and low specificity (culture and microscopy methods not being able to efficiently differentiate between M. tuberculosis and non-tuberculosis mycobacteria). Furthermore, none of these approaches are able to rapidly and efficiently identify a patient’s resistance to the major drugs for treating TB — INH and Rif. Even if sequencing and Line Probe Assay are available to test drug resistance, the procedures are quite complicated and time-consuming.

“Making a fast and accurate diagnosis of the type of TB infection a patient may have is the most important step to curing a patient. Because MDR-TB is difficult to treat, preventing its spread throughout the population is essential. The Anyplex^™ MDR-TB Test is a powerful new tool that healthcare workers can use to rapidly determine MDR-TB infections, which will both help stop it from spreading and allow health care professionals to set a course of alternative medications for infected patients,” said Jong-Yoon Chun, chief executive officer of Seegene.

Anyplex^™ MDR-TB Test will not be available in the USA until regulatory clearance.

About Seegene

Seegene, Inc. is the leading biotechnology company developing, manufacturing and marketing innovative molecular diagnostic products. The company’s proprietary technologies in both PCR and Real-time PCR named ACP™, DPO™, and READ™, set a new solution for high-throughput and simultaneous multi-pathogen detection called “multiplex PCR”. The novel Real-time PCR technology, READ™, overcomes the limitations of conventional Real-time PCR, providing dramatic improvement in sensitivity and specificity. Seegene holds three novel Molecular diagnostic platforms: Seeplex^®  system adapting DPO™ Technology, Anyplex™ and Magicplex™ systems that are Real-time PCR detection platforms adapting DPO™ and READ™ technologies. Seegene’s products detect multi-pathogens with great reliability and throughput, ultimately providing the most economical basis for saving time, labor and cost. Seegene’s mission is to maintain leadership in molecular diagnostics for infectious diseases, genetics, pharmacogenetics, and oncology using the innovative proprietary technologies.

For more information please visit www.seegene.com or call +301-762-9066.

WEST HARTFORD, CT–(Marketwire – July 20, 2010) –  ORLive, the vision of improving health, presents a live thoracoscopic maze procedure to cure atrial fibrillation from PinnacleHealth. In addition to this live procedure, ORLive invites you to take part in the latest installment of the Virtual Brain Tumor Board, and to watch and learn from this month’s featured channel of no-visible-scar surgeries.

NEW ON ORLIVE

LIVE SURGERY VIDEO – Total Thoracoscopic Maze
Live Wednesday July 21, 2010, 7:00 PM EDT

The total thoracoscopic maze is a surgical procedure intended to permanently cure atrial fibrillation. This minimally invasive, beating heart procedure will be performed by Dr. Mubashir Mumtaz, Chief of Cardiothoracic Surgery at PinnacleHealth. 

Viewers are invited to interact with the surgical team by submitting questions via the ORLive website. To learn more about this broadcast and to sign up for an e-mail reminder go to ORLive.com.

ORLIVE REFERRALS – Week of July 19, 2010
Each week ORLive highlights on-demand videos for our membership and visitors. 

No Visible Scar Surgery Referral: Laparo-Endoscopic Single-Site (LESS) Procedure from Tampa General Hospital

CME Referral: Minimally Invasive Endoscopic Pituitary Surgery from Thomas Jefferson University Hospital

Viewer’s Referral: Whipple Procedure for Pancreatic Cancer from University of Maryland Medical Center

HIGHLIGHTS

NOW ON-DEMAND – The Anterior Supine Approach to Total Hip Arthroplasty
Now Available On-Demand

ORLive and Zimmer present a Total Hip Arthroplasty featuring the Continuum Acetabular System and the Fitmore Hip Stem. The surgery was originally presented live and was performed by Dr. Jonathan Yerasimides, University of Louisville Department of Orthopaedics, Louisville, KY and is moderated by Dr. Hari Bezwada, University of Pennsylvania School of Medicine Department of Orthopaedic Surgery, Philadelphia, PA. This video presents the entire surgical procedure, and provides an opportunity for firsthand insight of the safe and effective implantation and surgical procedure involved with the Continuum Acetabular System and the Fitmore Hip Stem.

This surgery video is available to members of the ORLive community, and members are still able to interact and ask questions via the ORLive website. Learn more about this broadcast at ORLive.com, and be ready to view this exciting procedure by activating your free membership to ORLive today.

PREVIEW – Prenatal Pediatrics
Premieres Tuesday, July 27, 12 PM EDT

Managing a high risk pregnancy can be difficult. NewYork-Presbyterian Morgan Stanley Children’s Hospital provides the maternal, fetal and pediatric expertise to care for high-risk pregnancies. NewYork-Presbyterian Morgan Stanley Children’s Hospital was one of only eight hospitals in the country ranked in each medical specialty measured by U.S. News & World Report, with distinct leadership in neonatology and pediatric cardiac surgery.

Watch the best in Prenatal Pediatrics July 27th at Noon.

Viewers of this video are invited to interact with the team via the ORLive website, and to join the community and receive regular updates from the NewYork-Presbyterian Morgan Stanley Children’s Hospital Center for Neonatal Pediatrics.

SUPPLEMENTAL CONTENT – VOX ORLive
Explore robotic assisted mitral valve surgery with cardiac surgeon Dr. Lynn Seto in the current episode of VOX ORLive, an audio podcast featuring the latest advancements in medicine, surgery, and medical technology.

About ORLive
ORLive is the leading provider of video communication channels to the healthcare community. Working collaboratively with hospitals and device manufacturers, ORLive produces and distributes customized, interactive, video programs that demonstrate the latest advances in medicine, surgical techniques and product innovations. The ORLive broadcasting network provides an intimate look at over 650 live and on-demand surgeries to a global audience, streaming over 50,000 hours of programming each month. The ORLive network can be found on-line at www.ORLive.com.

id=”nav_links”>

DENVER, CO–(Marketwire – July 20, 2010) – Though statistics vary, most clinicians and dietitians agree — eating disorders are on the rise. To address this growing epidemic and discuss innovative treatment strategies, leading eating disorders professionals will gather in Denver August 13-14, 2010, at the 2^nd Annual Rocky Mountain Eating Disorders Conference. 

Held at the Denver Marriott City Center in Denver, Colo., the conference is hosted by Eating Recovery Center, a national center for eating disorders recovery providing comprehensive treatment for anorexia and bulimia. CEUs are now available for several disciplines.

For the second consecutive year, the conference will focus on new treatment trends for anorexia nervosa, bulimia nervosa and EDNOS; as well as innovative strategies for addressing the complexities of these disorders. 

“Collaboration within the eating disorders community ultimately leads to better outcomes for our patients,” said Kenneth L. Weiner, MD, CEDS, founding partner and medical director of Eating Recovery Center. “At the Rocky Mountain Eating Disorders Conference, individuals have the opportunity to learn best practices and treatment innovations from some of the leading minds in the field.”

Here is a brief sampling of sessions and speakers:

• Key Ingredients for Creating a Center of Excellence: A Primer for Building a Successful Program, Kenneth L. Weiner, MD, CEDS
• Escaping the Wilderness: Recovery from Anorexia, Emmett R. Bishop, Jr., MD, CEDS
• Medical Complications of Anorexia Nervosa and Bulimia, Philip Mehler, MD, FACP, CEDS
• The Willing and Able: Understanding the Adolescent Brain in the Treatment of Eating Disorders, Ovidio Bermudez, MD, FAAP, FSAM, FAED, CEDS
• New Models of Family Therapy in the Treatment of Eating Disorders, Craig Johnson, PhD, FAED, CEDS
• The Mindful Therapist, Carolyn Costin, MA, Med, MFT, CEDS

Registration is $150 and includes all sessions, dinner on Friday night, continental breakfast and lunch on Saturday, as well as refreshment breaks. Single-day registration is $75. Student-discounted registration is $100 and $50 for single-day attendance. Space is limited and registration prior to the event is recommended.

For more information or to register for the 2^nd Annual Rocky Mountain Eating Disorders Conference, visit Eating Recovery Center’s website or call 877-218-1344.

About Eating Recovery Center
Eating Recovery Center is a national center for eating disorders recovery, providing comprehensive treatment for anorexia and bulimia at the foot of the Rockies in beautiful Denver, Colorado. Facilities include a licensed behavioral hospital treating adults, an outpatient office, and an adolescent facility scheduled to open in November 2010. Our integrated program offers patients from across the country a continuum of care that includes inpatient, residential, partial hospitalization, intensive outpatient and outpatient services. Our compassionate team of professionals collaborates with treating professionals and loved ones to cultivate lasting behavioral change. For more information please contact us at 877-218-1344 or [email protected] or confidentially chat live on our website at www.EatingRecoveryCenter.com.

Click here to see all recent news from this company

LOS ANGELES, CALIFORNIA–(Marketwire – July 20, 2010) – The Medical Tourism Association, known for setting trends in the industry, announces new strategic initiatives under the theme progress in motion for global healthcare stakeholders, allowing them to discover & learn about intense topics of medical tourism, extending networking opportunities enhanced by dedicated sessions and creating knowledge sharing possibilities between government, insurance, healthcare and tourism professionals during THE World Medical Tourism & Global Healthcare Congress, taking place in LA from September 22nd – 24th. http://www.medicaltourismcongress.com.

“We recently announced our extensive agenda, today we are announcing the list of incredible speakers, coming exclusively with the sole purpose of providing a learning platform for industry stakeholders. We are particularly encouraged at the number of high level government officials who are attending the ministerial summit which indicates growing support from all sectors for medical tourism initiatives, especially ministers of health, tourism and economic development,” said Jonathan Edelheit, CEO of the Medical Tourism Association.

MTA team worked relentlessly this year to identify and invite top government officials from across the world, eminent professionals from US & International Insurance Companies, alongside some of the largest US and International Employers, on another hand, leading medical tourism experts and top global healthcare providers are revisiting the congress.

“Though we have received tremendous responses, we are receptive to have more top-notch experts and professionals to utilize the platform to share their knowledge, experience and expertise,” added Edelheit, inviting leading speakers to join congress by submitting white papers at http://www.medicaltourismcongress.com/en/speakers.html .

The congress is the biggest networking opportunity platform in the world for medical tourism and global healthcare related affairs. The addition of the “Buyers of Healthcare VIP Program” is also a unique feature which was added to create more interesting and one on one business meetings for all delegates and sponsors, bringing up to 200 employers, insurance companies, agents and medical tourism facilitators who are involved in or interested in patients traveling across borders for healthcare. 

“Networking is the spirit of our congress. We realize that social media and electronic channels can’t replace one-on-one meetings. Last year we got incredible responses and many delegates mentioned networking alone provided ROI, while learning & sharing experience was nothing but overwhelmingly a delightful experience,” says senior meeting manager Silvana Maldonado, working exclusively for networking and meeting sessions.

While extensive agenda, green healthcare initiative, learning opportunities, networking possibilities and knowledge sharing are base of the congress, seasoned speakers are the main focus which makes this a comprehensive Medical Tourism Mecca gathering.

• Karen Beyer – Director of Global Benefits, General Electric

• Mr. Jose M. Loaiza – Senior Network Manager, Blue Shield of California

• Premier W. McKeeva Bush – Premier, Cayman Islands

• Joanne Armenio – Director, International Benefits, Kraft Foods

• Bob Ihrie – Senior VP of Employee Rewards and Services, Lowe’s Companies, Inc.

• Luis Fernando Moreas – Secretary of Tourism, Porto Alegre Brazil

• Kathy Clark – Compensation & Benefits Analyst, Blackbaud, Inc.

• Anthony Amato – VP Compensation & Benefits, Discovery Communications

• Kevin M. Fickenscher, M.D., CPE, FACPE, FAAFP – Chief Strategy and Development Officer, Dell Services

• H. E. Mr. Nasser Al Budoor – Director, Ministry of Health, UAE, International Relations & Health Affairs and Director of Health Minister’s Office

• Cheryl Matheis – Senior Vice President for Health Strategy, AARP

• Laila Al Jassmi – CEO, Clinical Support Services Sector, Dubai Health Authority

• David M. Cheek – Vice President of Sales, Pan American Life Insurance Group

• Dr. Shetty – Heart Surgeon of India & Founder of Hospital Investment Project, Cayman Islands

• Michael Bertaut – Senior Healthcare Intelligence Analyst, Blue Cross and Blue Shield of Louisiana

• Jeff A. Argotsinger – Director, Business Leader Medical Expense Group, Swiss Reinsurance Company

• Dr. Hisham Diwani – General Manager, Health Insurance, Ministry of Health Syria

• Bavdeep Singh – CEO, Fortis Healthcare India

• Emilio M. Williams – Managing Director, Johns Hopkins Medicine International

• Dr. Rick van Pelt – Director Global Programs, Partners Harvard Medical International

• Mark Scotland – Minister of Health, Cayman Islands

• Jonathan Hart – Chief Medical Officer, International Medical Group

• Pamela Frank – International Health Services Coordinator, Children’s Hospital of Boston

• Fred Hagigi – Director, Executive Education Programs Professor of Health Services, UCLA School of Public Health

• MaryBeth Kramer – Sr. Manager, Global Benefits and HR Services Compensation and Benefits, Verisign

• Shady Fawzy Nawar – Assistant Vice President – Provider Management, Qatar Insurance Company-Doha

• Arthur L. Diskin, MD, FACEP – Vice President and Global Chief Medical Officer, Royal Caribbean, Celebrity and Azamara Club Cruises

• Martha Turnbull – Travel Health Insurance Association of Canada

• Linda Cote – AGB Sales Director Pacific Region, Aetna

• Dr. Jeannette Takemura – Dean of School of Social Work, Columbia University

• Alexander Sander Domaszewicz – Principal and Senior Consultant, Mercer Health & Benefits Services

• Robert S. Shestack – WBC, Managing Director, National Sales Leader, Employer Benefits Business, Marsh U.S. Consumer, a service of Seabury & Smith, Inc.

• Brad Cook – International Patient Department, Hospital Clinica Biblica, Costa Rica

• Renee-Marie Stephano – President, Medical Tourism Association

• Jonathan Edelheit – CEO, Medical Tourism Association

• Ralph Lawson – Executive Vice President and Chief Financial Officer
  Baptist Health South Florida

• Greg Carlson – Assistant Professor, University of Alabama, Department of Health Services

• Jason B. Krouse – Executive Vice President, Univers Workplace Benefits

• William Cook – International Patient Department, Hospital Clinica Biblica

• Dr. Prem Jagyasi – MD & CEO, ExHealth Dubai

• Tom O’Hara – President, Surgical Trip LLC

• Dr. Antonia Arnaert –Vice-President, Debson Medical Tourism

• Dr. Narottam Puri – President, Medical Strategy & Quality, Fortis Healthcare

• Wouter Hoeberechts – CEO, WorldMed Assist

• Doug Wojcieszak, Founder, Sorry Works!

• Richard Polak, President & CEO, IBIS Advisors

• Derrell Connor, Account Executive, M3 Insurance Solutions for Business (M3)

• Tom Hamilton – President, Carolina Benefit Designs

• Daniel Friedland – MD, Founder & CEO, SuperSmartHealth

• Jason Woods – Fairmont Specialty Group

• Sonia Roschnik – Operational Director, NHS Sustainable Development Unit, UK

• C. Duane Dauner – President, California Hospital Association

• Stephen Hartigan – Chief Executive Officer, InterGlobal Insurance Company Ltd. (IGIC)

• Peter Lozier – Executive Vice President Sales, Marketing and Provider Relations, CMN Inc.

• Dr. Myles Druckman – Vice President Medical Services, Americas Region
  International SOS Assistance, Inc

• Dean Stone – Manager Workers Compensation and Governance, National Australian Bank

• Stuart Rowley – CEO, Prince Court Medical Center, Malaysia

To view a full list of speakers please CLICK HERE or go to http://medicaltourismcongress.com/en/speakers.html.

Join us for the VIP After Party

The World Medical Tourism & Global Healthcare Congress is also known for its networking cocktail receptions following the general sessions. On Wednesday, September 22, 2010 all registered delegates will be invited to share in an entertainment filled networking session jointly held with the Employer Healthcare Congress where up to 1000 employers, insurance agents, brokers, consulting firms and healthcare leaders will finishing up their three day congress event on the Green Circle Terrace. For more information about the VIP After Party, please go see the video at http://www.medicaltourismcongress.com/en/vip-party.html .

Additional Giant Leaps for 2010

The World Medical Tourism and Global Healthcare Congress includes two additional conferences which are the Expatriate Healthcare, Travel Insurance and Global Health Insurance Conference, http://www.expatriateconference.com and the Sustainable Healthcare and Hospital Development Conference, http://www.healthcaredevelopmentconference.com . Speakers listed above are from all three conferences.

The Medical Tourism Association™ (Global Healthcare Association) is the international non-profit trade association for the medical tourism and global healthcare industry made up of the top international hospitals, healthcare providers, medical travel facilitators, insurance companies, and other affiliated companies and members with the common goal of promoting the highest level of quality of healthcare to patients in a global environment. http://www.medicaltourismassociation.com. 

Marketing & PR by ExHealth / www.ExHealth.com

SILVER SPRING, MD–(Marketwire – July 20, 2010) – A critically needed modular laboratory facility is en route to Port-au-Prince thanks to a collaboration between the Association of Public Health Laboratories (APHL) and International Relief Solutions, LLC (IRS). The APHL Haiti Field Laboratory Support Team provided technical assistance to International Relief Solutions, LLC (IRS) in planning and design of the new laboratory, which will replace the temporary tent facility that has served the nation’s largest hospital since the January earthquake. 

The 24′ by 36′ modular laboratory will be erected at L’Hôpital de l’Université d’État d’Haïti (HUEH). Since the earthquake, the number of patients being treated at HUEH has tripled from 14,000 per month to almost 42,000 thus increasing demands for laboratory testing. Due to extremely high temperatures and no air conditioning in the tent, automated testing requiring cooler temperatures, such as hematology and blood chemistry, are being run manually. The result is that the current testing capacity is only 25% of the daily demand. The modular lab facility is designed with infrastructure for work benches, heating, ventilation, plumbing and electrical services. With direct hookup to electrical and water supplies, the laboratory building will have the air conditioning necessary to meet the requirements of the many intricate and delicate tests that the laboratory technicians on scene perform routinely. The lab will arrive with the electrical system and plumbing pre-installed allowing for a quick start-to-finish set up of approximately four days.

APHL Senior Technical Consultant and Team Leader for the APHL Haiti Field Laboratory Support Team, Dave Doherty, coordinated this effort from start to finish. Following the earthquake, the Centers for Disease Control and Prevention requested and authorized Doherty and his team to assist all of the public health network laboratories in Haiti in getting testing services back up and running to support the enormous demands for medical care and treatment. 

Better lab facilities will improve testing services and also enable laboratory technologists to get back to work. According to Doherty, “Many well-trained technologists in Haiti are unable to work and provide testing services because of the loss of laboratory facilities to earthquake damage.”

It could be years before the permanent structures are rebuilt; the new modular lab serves as a long term solution. This initiative was a success due to the collaboration of willing and committed partners, each of whom brought essential resources and expertise to assure an effective solution for meeting a critical need in Haiti. Lives will be saved and illnesses treated effectively because of the efforts of APHL, IRS and CDC. Doherty modestly explains, “We were able to come through. APHL has always come through in Haiti.”

The Association of Public Health Laboratories is a national non-profit located in Silver Spring, MD, that is dedicated to working with members to strengthen governmental laboratories with a public health mandate. By promoting effective programs and public policy, APHL strives to provide public health laboratories with the resources and infrastructure needed to protect the health of US residents and to prevent and control disease globally.

Click here to see all recent news from this company

SAUNDERSTOWN, RI–(Marketwire – July 20, 2010) – For the small practice healthcare provider, selecting an Electronic Health Record (EHR) system can be a daunting task, with more than 300 vendors, complicated pricing, and products that are impossible to evaluate for usability, effectiveness, and implementation times. Oftentimes this leads to buyer’s remorse and later switching to another EHR.

Due to its industry-leading user satisfaction ratings in multiple studies, $995 price tag, and three month risk-free trial offer, Amazing Charts has quickly emerged as the EHR-of-choice for small practices.

Founded and designed by physician Jonathan Bertman, MD, FAAFP, specifically for offices with three or fewer providers, Amazing Charts enables rapid documentation of patient encounters, with fewer errors, faster coding, and ePrescribing. In most cases, no training is required for first-time users. Amazing Charts is a CCHIT Certified® 2008 Ambulatory EHR additionally certified for Child Health.

Gordon Comstock, MD, practices family and geriatric medicine in Arcade, New York, a low-income area of the state. His medical practice has over 3,000 patients, many of who are elderly and on fixed incomes.

At his former practice, Dr. Comstock saw his colleagues “spend nearly $280,000 on an EHR system they found to be unwieldy and difficult to use.” He notes that there were way too many little pull-down menus and data fields, forcing him to “dictate notes anyway because [he] couldn’t document notes during a visit.” Additionally, the practice had to hire a full-time person just to scan paper documents like referral letters and lab reports into the EHR.

Today he uses Amazing Charts to run his entire office.

Says Dr. Comstock, “Amazing Charts is the closest an EHR can get to how a family doctor likes to generate a note. Many of the referral letters I see from specialists are indecipherable because they are generated by EHRs that don’t communicate what the specialist actually saw and thought. Amazing Charts always allows me to express myself in a way that captures not only the data points, but also the subjective narrative of my thoughts and observations.”

Another practice, Community Medical Group in Downey, California, had a different set of problems. After decades in operation, the three physician practice had amassed over 7,200 patients and their charts had become a significant obstacle to keeping the office running.

According to Dr. Martin Sechrist, “specific charts were hard to track down, the filing backlog was lengthy, and it was often difficult to match charts with filings.” 

With Amazing Charts, every patient has an electronic health record that can be accessed from any computer in the office, remotely, or via a simple iPhone app.

Says Dr. Sechrist, “Amazing Charts mirrors the way we conduct patient encounters, and makes immediately available all patient demographics, imported items, and a patient summary of current issues, medications, and prior encounters. Even outside laboratory results are imported directly into the electronic medical record!”

Amazing Charts automatically generates an electronic “super-bill” whenever a note is signed, and records are backed up daily in a secured database on-site.

Amazing Charts V5 can be downloaded for a free, three-month trial at http://www.amazingcharts.com.

About Amazing Charts
AmazingCharts.com provides Electronic Health Record (EMR) software and services to small and medium sized healthcare practices. Used by more than 3,600 practices in the U.S., Amazing Charts has been growing by over 70 new practices each month, based on its high ratings for quality, price, support, ease of use, and impact on productivity. For more information visit www.amazingcharts.com or call 1-866-382-5932.

Click here to see all recent news from this company

ALEXANDRIA, VA–(Marketwire – July 20, 2010) – Pregnancy is a time of wonder and amazement — and for women with pre-existing diabetes, it is also a time for very extremely careful (and sometimes baffling) disease management. How do you plan for this? What risks are involved? What can you expect? The August issue of Diabetes Forecast, the consumer magazine of the American Diabetes Association, features articles about pregnancy with pre-existing diabetes to help you. With good care and planning, says Diabetes Forecast, women with either type 1 or type 2 diabetes can have safe pregnancies — and healthy babies.

Planning starts now. If you have diabetes and want to become pregnant, the first step should be visiting your doctor — or several doctors. Depending on your diabetes management, you may want to see an endocrinologist in addition to your ob-gyn for a pre-conception visit. When choosing your doctors, keep in mind that you may have appointments as often as twice a week, so try to find a physician that you are comfortable with and whose office you are comfortable getting to.

While pre-existing diabetes automatically puts your pregnancy in the high-risk category, healthy habits can lower the chance of problems for both mother and child. First and foremost, keep your blood glucose in check — in general, your A1C should be below 7 percent before you conceive. Your health care team may also want to discuss your weight, use of prenatal vitamins and other supplements, the status of any diabetes-related complications, and your current medications (such as ACE inhibitors or statins, which are not considered safe for use in pregnancy). Polycystic ovary syndrome is associated with type 2 diabetes, so for some women with diabetes, asking about fertility treatments may also be in order.

Once you become pregnant, your body’s changes can make blood glucose levels go from one extreme to the other. “I spent the entire first trimester with my face buried in the fridge,” says Kerri Sparling, 31, who has type 1 diabetes and whose daughter was born in April. “I was low all the time. It wasn’t until probably the second trimester that the insulin resistance kicked in. Everything I ate, the insulin didn’t cover it.” As your body changes through your pregnancy, so will its reactions to the elements you normally use to manage your blood glucose, so be prepared to communicate with your health care team often and make any necessary adjustments.

From pre-conception planning to integrating diabetes management into your birth plan and facing post-partum depression, having a baby can seem like an overwhelming task for women with diabetes, and yet, many women with diabetes find they have the best glucose control of their life during pregnancy. “This was so, so important to me that I was willing to do whatever to make sure she came out right,” says Sparling. “It’s so worth it.” Find more advice, explanations and insight about what to expect in the August issue of Diabetes Forecast.

This issue of Diabetes Forecast also features:

• A Birthday Challenge: Marking 40 years with 40 races for ADA’s Team Diabetes
• Drinking Calories: How you hydrate yourself makes a difference
• A Serious Subject: Dealing with erectile dysfunction

Diabetes Forecast has been America’s leading diabetes magazine for more than 60 years, offering the latest news on diabetes research and treatment to provide information, inspiration and support to people with diabetes. 

The American Diabetes Association is leading the fight to stop diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure, and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, its mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information, please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.

id=”nav_links”>

NEW YORK, NY–(Marketwire – July 20, 2010) –  Interactivation Health Networks, parent company of the Newborn Channel and Patient Channel, the nation’s most comprehensive in-hospital TV networks, today announced that Dammand Cherry will serve as Account Executive, Ad Sales, for both channels.

Dammand’s extensive experience in pharmaceutical media sales and agency management will provide advertisers with an additional point of contact intimately familiar with the pharmaceutical industry’s advertising needs and expectations.

“The pharmaceutical industry has always been an important partner for the Patient and Newborn Channel,” said Suzanne Fleming, SVP of Sales at Interactivation Health Networks. “Dammand’s experience in the health media space shows our continued commitment to personally cater to this industry, making it even easier for them to achieve a focused and effective out-of-home advertising campaign. We are thrilled to have him on-board as demand for both networks continues to grow.”

Newborn Channel and Patient Channel provide marketers with unparalleled access to their target consumers in a highly trusted environment. 

About Interactivation Health Networks
The Patient Channel and The Newborn Channel are the most comprehensive in-hospital TV networks. Delivered directly to patient rooms and waiting areas, the Channels provide viewers with original, award-winning health programs and advertisers with the unique ability to integrate brand messaging with content that is compelling and endorsed by healthcare professionals. The Newborn Channel broadcasts baby care and postpartum programming for new parents, reaching 60% of new moms. The Patient Channel features both condition-specific and preventative health programming to empower and inform patients. The channels are currently available in over 2,700 hospitals nationwide. For more information, visit http://interactivation.com/news/index.php/interactivation-health-networks/.

ROCKVILLE, MD and SEOUL, KOREA–(Marketwire – July 20, 2010) – Seegene today announced the availability of Magicplex™ Sepsis, a new multi-pathogen screening test capable of quick and accurate identification of over 90 leading sepsis-causing pathogens. Magicplex Sepsis provides a novel and fast-acting diagnostic technique for hospitals to simultaneously verify a complex range of targets that indicate sepsis, the leading cause of death in non-coronary intensive care units worldwide. Seegene’s Magicplex Sepsis will be introduced at the 2010 Annual Meeting and Clinical Lab Expo of the American Association for Clinical Chemistry (AACC), booth # 1800.

Sepsis is a deadly disease that leaves no clear track back to initial indications, which could include gram-positive bacteria, gram-negative bacteria or fungi. The results are devastating: the annual incidence rate of sepsis has increased 91.3 percent over the last 10 years, and every hour 25 people in the United States die from severe sepsis. One of every three patients who develop severe sepsis will die within a month. Severe sepsis, the leading cause of death in the non-coronary intensive care unit, takes more lives than breast, colorectal, pancreatic, and prostate cancers combined.

The medical challenge to be overcome is to determine the correct treatment of sepsis within the first hours of the onset of the disease. Currently physicians and clinicians have little option but to run several available molecular diagnostic tests that offer little confidence that the results will definitely identify the presence of sepsis in a patient. The alternative to these relatively quick tests is a multiple-phase blood culture test, which is a time-consuming process, or current multiplex PCR with limited range of pathogen targets and poor test specificity. 

Seegene’s Magicplex Sepsis Test is a sharp break from this mold. Magicplex Sepsis is a real-time detection test that quickly and comprehensively determines the levels of suspected targets in a patient’s blood sample, and identifies drug resistant genes to better inform a diagnosis. The speed, accuracy and price of the Magicplex Sepsis Test will enable doctors and clinicians to quickly provide an appropriate treatment to head off the deadly disease.

The Magicplex Sepsis Test simultaneously screens for over 90 sepsis-causing pathogens: over 70 Gram (+) (30 Staphylococcus, 40 Streptococcus, 3 Enterococcus); 12 Gram (-); 6 Fungi; and 3 antibiotic resistant genes (mecA, vanA, vanB) can also be discriminated. The Magicplex Sepsis Test requires less than 1ml of patient’s whole blood and provides test results within three hours (after extraction). The test’s unique performance is a function of separate screening and identification steps. For example, when screening for over 90 sepsis-causing pathogens, the identification of exact pathogens can be carried out without starting from blood collection. 30 different pathogens are organized in different panels for identification and it only takes 40 minutes to detect.

“The Magicplex Sepsis Test will be the new gold standard for performing accurate, rapid and cost-effective sepsis diagnosis,” said Jong-Yoon Chun, chief executive officer of Seegene. “In treating sepsis, time and accuracy are demanded. Every hour of delay in giving patients the correct antibiotics results in an 8% increase in the mortality rate.”

“For doctors and clinicians performing faster diagnosis than by blood culture is a dream come true. By enabling doctors to make accurate diagnosis faster, Magicplex Sepsis can lead to improved patient outcomes in health care settings worldwide,” said Hong-Soo Kim, MD, Department of Internal Medicine, Institute of Gastroenterology, Soonchunhyang University College of Medicine, Korea.

Magicplex tests are based on Seegene’s proprietary READ™ technology, which combines the advantages of multiplex in a real-time system. The result is a molecular diagnostic testing system that provides higher specificity and sensitivity over currently available PCR systems.

The READ technology of Magicplex tests is a departure from probe- and primer-based PCR methods to produce false-free detection. Magicplex test works in a simple two-step process: first specifically amplifying the DNA sequence of target pathogens, then simply reading those signals using any real-time PCR instrument.

Magicplex Sepsis Test will not be available in the USA until regulatory clearance.

About Seegene

Seegene, Inc. is the leading biotechnology company developing, manufacturing and marketing innovative molecular diagnostic products. The company’s proprietary technologies in both PCR and Real-time PCR named ACP™, DPO™, and READ™, set a new solution for high-throughput and simultaneous multi-pathogen detection called “multiplex PCR.” The novel Real-time PCR technology, READ™, overcomes the limitations of conventional Real-time PCR, providing dramatic improvement in sensitivity and specificity. Seegene holds three novel Molecular diagnostic platforms: Seeplex^®  system adapting DPO™ Technology, Anyplex™ and Magicplex™ systems that are Real-time PCR detection platforms adapting DPO™ and READ™ technologies. Seegene’s products detect multi-pathogens with great reliability and throughput, ultimately providing the most economical basis for saving time, labor and cost. Seegene’s mission is to maintain leadership in molecular diagnostics for infectious diseases, genetics, pharmacogenetics, and oncology using the innovative proprietary technologies.

For more information please visit www.seegene.com or call +301-762-9066.

WORTHINGTON, OH–(Marketwire – July 20, 2010) –  American Health Holding, Inc., a multi-URAC accredited medical management service provider, today announced the expansion of its Disease Management (DM) program to provide more program options to help clients contain costs while assisting individuals managing a chronic condition.

“We heard our customers’ request for a DM program that addresses those most in need of health management intervention,” states Paul Lavin, American Health’s President. “We felt our new High Risk Disease Management program was a solution. While American Health’s Comprehensive DM program targets approximately 20% of a client’s population, the new High-Risk program reaches the 5.5% who are at the highest risk for incurring large health care claims.”

In March 2009, American Health launched its new Population Health Management (PHM) program. Comprised of both DM and Lifestyle/Wellness components, PHM takes aim at helping benefit providers address rapidly rising health care costs while assisting individuals in achieving optimal health. At the start of the program, DM addressed seven chronic conditions for which evidence-based guidelines are established to impact health and measure improvement: asthma, chronic obstructive pulmonary disease, congestive heart failure, coronary artery disease, diabetes, hyperlipidemia, and hypertension.

“In addition to introducing our high-risk program, we have added chronic pain as the eighth condition that we manage,” notes Anne Klie, Director of Product Development and Marketing. “We recognized that by using our proven behavioral assessment and modification tools we can make a difference in the lives of people suffering from low back pain and osteo- and rheumatoid arthritis.”

Earlier this year, American Health’s participant satisfaction survey revealed that 100% of first-year participants would be likely to recommend the program. “We are pleased with our preliminary outcomes, and we look forward to continue enhancing the program experience for our members,” adds Lavin.

About American Health Holding, Inc.
American Health Holding is a single-source provider of medical management services that supports millions of members across the health care continuum. The multi-URAC accredited organization has been helping clients to maximize cost savings while ensuring the quality and appropriateness of care since 1993. American Health provides a level of flexibility that supports integrated solutions for creating healthy outcomes. For more information about American Health visit the Web site: www.AmericanHealthHolding.com.

Click here to see all recent news from this company

WAYNE, PA–(Marketwire – July 20, 2010) – Clinical and Laboratory Standards Institute (CLSI) recently published “Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement (June 2010 Update)” (M100-S20-U).

This update includes:

• New interpretive criteria for doripenem for Enterobacteriaceae
• Revised interpretive criteria for ertapenem, imipenem, and meropenem for Enterobacteriaceae
• Guidance for use of the modified Hodge test (MHT) with revised interpretive criteria for carbapenems

Jean B. Patel, PhD, D(ABMM), Deputy Director, Office of Antimicrobial Resistance, Centers for Disease Control and Prevention, and member of the subcommittee that developed the update, says, “Carbapenemase-producing Enterobacteriaceae are a significant infection control concern, and rapid laboratory detection of isolates that may carry these resistance mechanisms is an important step in preventing transmission. Since these isolates will test nonsusceptible (ie, intermediate or resistant) to one or more of the carbapenem agents using the revised breakpoints, it will be easier for laboratories to identify these isolates and to report their findings to hospital infection preventionists.”

Michael N. Dudley, PharmD, FCCP, FIDSA, Senior Vice President, Research & Development and Chief Scientific Officer, Mpex Pharmaceuticals, Inc., and member of the subcommittee that developed the update, agrees, “It was important to provide further direction to laboratories on detection of isolates with reduced susceptibility to carbapenems. Unfortunately, there are no reliable clinical studies that allow assessment of the clinical response to treatment of carbapenem-producing strains to carbapenem antimicrobial agents. However, studies in animal models indicate that the minimal inhibitory concentration (MIC) is the best predictor of antibacterial effects. The new MIC breakpoints, coupled with US Food and Drug Administration (FDA)-approved dosage regimens used frequently in the clinic, provide for a better probability of attaining pharmacokinetic/pharmacodynamic exposures associated with antibacterial effects in vivo. The new intermediate and resistant breakpoints for carbapenems also ‘capture’ a majority of isolates that produce carbapenemases that can be confirmed using the MHT, if needed.”

He adds, “This new update will help laboratories improve quality and provide timelier reporting of susceptibility results.”

Tracy Dooley, MLT(ASCP), CLSI Standards Administrator, explains the importance of publishing a midyear update to the well-known annual antimicrobial susceptibility testing (AST) breakpoints, saying, “In an effort to disseminate information to users in a timelier manner, the Subcommittee on AST decided to publish a midyear M100 supplement with the new/revised carbapenem interpretive criteria for Enterobactericeae. This midyear publication allows laboratories to begin to initiate the implementation of these changes. One of the benefits of the new interpretive criteria is that nearly all carbapenemase-producing isolates will test nonsusceptible to one or more carbapenems. This alleviates the need to perform initial screening and confirmatory testing (MHT) for routine patient testing. Historically, each complete blood count (CBC) instrument/reagent manufacturer developed its unique approaches to system validation and performance claims. This standard will help create better standardization among manufacturers, as well as assist practicing laboratories in developing consistent testing.”

The tables in this M100-S20 June 2010 Update are to replace Tables 2A and 2A-S2 in
Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement (M100-S20) (January 2010). For other tables referenced in this update, please see M100-S20 (January 2010).

CLSI is a volunteer-driven, membership-supported, nonprofit organization dedicated to developing standards and guidelines for the health care and medical testing community through a consensus process that balances the perspectives of industry, government, and the health care professions. For additional information on CLSI, visit the CLSI website at www.clsi.org or call 610.688.0100.

Click here to see all recent news from this company

VANCOUVER, BRITISH COLUMBIA–(Marketwire – July 20, 2010) – According to new spinal implant reports by iData Research (www.idataresearch.net), the leading global authority in medical device and pharmaceutical market research, the U.S. market for spinal implants is estimated to exceed $8 billion by 2016, while the MIS spinal implant market is estimated to reach over $3 Billion. In addition, rapid growth in artificial disc use will fuel the spinal motion preservation market to increase six-fold by 2016.

While many have predicted the cannibalization of spinal fusion procedures by motion preservation, iData’s report reveals healthy growth in the fusion market driven by a consistent rise in minimally invasive surgical (MIS) interbody procedures, the market for which will triple by 2016.

“Lateral lumbar interbody fusion, such as NuVasive’s XLIF^(R) (NASDAQ:NUVA), is the most rapidly increasing MIS interbody fusion procedure,” says Dr. Kamran Zamanian, CEO of iData.

Despite growth in spinal fusion, the competing spinal motion preservation market, which includes cervical artificial discs, is also expected to experience strong growth. Reimbursement policies for motion preservation devices are expected to continue to drive this market.

“The cervical artificial disc segment is aiding strong growth in the spinal motion preservation market,” says Dr. Zamanian. “Companies such as DePuy, Medtronic and Synthes are leading the market, while many competitors such as Cervitech, Globus, NuVasive, SpinalMotion, and Zimmer are expected to emerge into this segment in the next few years.”

iData’s global report series on the “Markets for Spinal Implants & VCF 2010” and the “Markets for Minimally Invasive Spinal Devices 2010” also covers VCF, spinous process fixation, facet fixation and MIS pedicle screws.

For more information, register free on iData’s website at: http://www.idataresearch.net/idata/registration.php

About iData Research

iData Research (www.idataresearch.net/idata/discoveridata.php) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies.

FRIENDSWOOD, TX–(Marketwire – July 20, 2010) – TrinityCare Senior Living, Inc. (OTCBB: TCSR), today announced they have been awarded a patent for the Company’s interactive family communication system, Seniors In Touch (SIT).

“Seniors In Touch allows senior adults to use a simple touch screen computer system to send and recieve video messages, email, pictures, and other digital media,” says Brian Lang, Chief Executive Officer of SIT. “Family and friends from across town or across the nation can share messages, memories, and daily activity using the Internet, hand held technology, and other creative media. The award of this patent recognizes SIT’s technical and social media innovation.” The Company previously announced the implementation of this technology together with CoVideo Systems, a leader in providing video emailing, conferencing and presentation tools.

About Seniors In Touch

Seniors In Touch is an interactive communication system for senior adults and their families. Utilizing the latest in touch screen computing combined with established communication tools, seniors will be able to send text and video messages to persons in their contacts via a secure, user-friendly, touch interface. A family member serves as the administrator of the Seniors In Touch account to provide approved and safe interaction for the senior adult. Seniors In Touch will also provide photo-sharing services and limited web access for news, weather and sports that is approved by the administrator. The platform will also provide executive directors of senior living facilities a platform in which to communicate with both the senior adults and their families. For more information please visit www.seniorsintouch.com.

About TrinityCare Senior Living, Inc.

TrinityCare Senior Living (“TrinityCare”) develops, owns, and manages quality senior living facilities that focus on enriching the faith of the residents and providing state-of-the-art independent living, assisted living, memory care and adult day care services in a single location. The Company partners with local churches and developers for each facility and offers a wide range of both community and personal services to residents. TrinityCare is a rapidly growing company with three successful facilities currently operating in Texas and Tennessee. Near-term expansion plans target the Southeastern part of the United States. For more information please visit www.trinitycare.com.

TrinityCare is headquartered in Friendswood, Texas (Houston metropolitan area) and its common stock trades on the OTC Bulletin Board under the symbol “TCSR.”

Forward-Looking Statements

The information in this news release includes certain forward-looking statements that are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including statements related to the future financial performance of the Company. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Factors that could cause results to differ include, but are not limited to, successful execution of growth strategies, product development and acceptance, the impact of competitive services and pricing, general economic conditions, and other risks and uncertainties described in the Company’s periodic filings with the Securities and Exchange Commission.

DALLAS, TEXAS–(Marketwire – July 19, 2010) – Odyssey and VistaCare Hospice in Texas can help you learn more about the type of care required in the final stages of life. 

“People appreciate the care hospice provides,” said Dr. Luis Gonzales, M.D., a National Medical Director for Odyssey Hospice and VistaCare Hospice. “Over 98% of family members tell us they would recommend hospice in Texas to others, and oftentimes our patients and families tell us they wish they’d been told about hospice in Texas sooner. Despite this, there are a lot of misconceptions among people who have not experienced the support hospice in Texas provides.”

One of the major misconceptions is that hospice is a location where one goes to live out the very last days of their life.

But in fact, hospice in Texas is a philosophy of care, and not a specific location at which to receive it. According to the National Hospice and Palliative Care Organization (NHPCO), 69% of hospice patients receive care in what they consider their home. The remainder are cared for in a hospice inpatient facility or hospital. Odyssey Hospice and VistaCare Hospice in Texas provide care wherever the patient’s home may be – a house, assisted living community, nursing home, or even during a brief hospital stay.

“The reality is that most people – medical professionals or otherwise – often equate hospice with death, but the truth is that hospice in Texas is about life” said Dr. Gonzales. “This lack of understanding can lead to a large number of people who are served by hospice in Texas for only a few days. Unfortunately, in these cases the patient and their loved ones don’t receive all of the benefits hospice offers.” Hospice is designed by Medicare to be a 6 month benefit, with the ability to provide care beyond that time for persons who remain eligible. Hospice in Texas is about quality of life.

Hospice in Texas provides compassionate, patient-centered care that offers medical expertise, comfort and support for those nearing the end of life, while also offering assistance for their loved ones. Hospice in Texas is delivered by a team of professionals who are experienced and committed to providing specialized care to persons seeking comfort, relief from symptoms, and gentle guidance.

Odyssey Hospice and VistaCare Hospice provide personalized care based on the needs of each patient and family. As one of the most experienced providers of hospice in Texas and throughout the United States, Odyssey and VistaCare offers CareBeyond, clinical programs for persons coping with specific illnesses. Developed by multidisciplinary team members, Odyssey and VistaCare hospice in Texas recognizes that patients with lung disease, for example, are treated differently, and have very different needs from, dementia patients. Using evidence based clinical practices, CareBeyond offers additional, specialized care to meet unique needs. 

Those who are approaching the end of life typically fear dying in pain, dying alone and are concerned about their loved ones. Hospice in Texas helps with each of these concerns. At Odyssey Hospice and VistaCare Hospice in Texas, our team of professionals is committed to serving patient and caregiver needs, whether they are physical, emotional or spiritual. Hospice is there when care and support are needed most.

With the early involvement of hospice, pain and symptoms are managed quickly so that people are comfortable. Only then can they work on other important aspects of their life. When chosen earlier, hospice in Texas provides greater benefits that are received for a longer period of time, including the opportunity for reflection and closure.

Hospice in Texas also provides bereavement care for up to 13-months for surviving family members. Care may include phone calls, newsletters, memorial services, connection to community resources and support. 

If you would like to receive more detailed, local information about hospice in Texas, please click here for information pertaining to hospice in Houston, or here for more information regarding hospice in Dallas. Odyssey & VistaCare also have hospice locations, providing in-home and/or inpatient treatment, throughout Texas. 

To learn more about hospice in Texas, please visit http://local.odsyhealth.com, or call (806) 553-6166.

IRVING, TX–(Marketwire – July 14, 2010) –  VHA Inc., the national health care network, announced the formation of a national Value Based Purchasing (VBP) Advisory Panel. The panel, which consists of nationally-recognized experts, will help hospitals and clinicians transition into this new environment, where reimbursements are linked to quality and safety outcomes. The panel members were selected because they represent a broad array of clinical, operational, and behavioral disciplines with knowledge and experience related to specific components of the government’s value-based purchasing initiative or the environment in which it will operate. Through the efforts of the advisory panel, hospitals and clinicians will gain better insights into the choices and issues that arise with value-based purchasing. 

“The value-based purchasing environment is not simply about looking at performance measures and tracking progress,” said Trent Haywood, MD, JD, chief medical officer at VHA and a former deputy chief medical officer at the Centers of Medicare and Medicaid Services. “Instead, it is a new focus on how we can collectively create more value for patients, clinicians, and providers. For value creation to occur, we need broader insights into the choices we have. The diverse background and expertise of the panel provides these insights.”

Beginning Oct. 1, 2012, through its value-based purchasing program, CMS will link hospital payments to clinical quality and patient experience scores. Hospitals that don’t perform well could lose millions of dollars in Medicare reimbursements. In May 2010, VHA announced the creation of its Value Insurance Program Services, precisely designed to help member organizations focus on specific VBP performance improvement needs. 

“Reimbursement from payers, both government and private insurers, has long been based on the volume of care delivered, but the reimbursement model of the future will be based almost exclusively on the value that’s provided, and hospitals will struggle to adapt to this shift,” said panel member David B. Nash, MD, MBA, dean of the Jefferson School of Population Health. “The panel will provide unbiased insight into the changes that must occur across health care for implementation of value-based purchasing. Without this sort of guidance, the industry may be delayed in developing positive momentum to adopting value-based purchasing.”

The members of the VHA VBP Advisory Panel include:

1. Ann Scott Blouin, RN, PhD, Executive Vice President, The Joint Commission, Oakbrook Terrace, Ill.
2. Dale Bratzler, DO, MPH, President/CEO, Oklahoma Foundation for Medical Quality, Oklahoma City, Okla.
3. Eric A. Coleman, MD, MPH, Director, Care Transitions Program, Denver
4. Helen Darling, President, National Business Group on Health, Washington, D.C.
5. R. Adams Dudley, MD, MBA, Professor of Medicine and Health Policy, Associate Director for Research, Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco
6. Susan Edgman-Levitan, PA, Executive Director, John D. Stoeckle Center for Primary Care Innovation, Massachusetts General Hospital, Boston
7. Nancy Foster, Vice President for Quality and Patient Safety Policy, American Hospital Association, Washington, DC.
8. Judith Hibbard, DrPH, Senior Researcher, Institute for Policy Research and Innovation, Professor, Department of Planning, Public Policy and Management, University of Oregon, Eugene, Ore.
9. David Hunt, MD, FACS, Medical Director, Office of Provider Adoption Support, Office of the National Coordinator for Health IT, Washington, D.C.
10. Ann Jordan, PhD, Professor of Anthropology, University of North Texas, Denton, Texas
11. Beverly Jordan, RN, Vice President of Nursing/Chief Nurse Executive, Baptist Memorial Health Care, Memphis, Tenn.
12. Harlan M. Krumholz, MD, SM Harold H. Hines, Jr. Professor of Medicine and Epidemiology and Public Health, Yale University School of Medicine, New Haven, Conn.
13. Rob Maurer, PhD, Associate Professor, Health Systems Management, Texas Woman’s University, Dallas
14. David B. Nash, MD, MBA, Dean, Jefferson School of Population Health, Philadelphia
15. Greg Pawlson, MD, MPH, Executive Vice President, National Committee for Quality Assurance, Washington, D.C.
16. Michael Rapp, MD, JD, FACEP, Director of Quality Measurement & Health Assessment Group, Office of Clinical Standards and Quality, Centers for Medicare and Medicaid Services, Baltimore
17. Victoria Rich, RN, PhD, Chief Nurse Executive, Hospital of the University of Pennsylvania, Philadelphia
18. Meredith Rosenthal, PhD, Associate Professor, Health Economics and Policy, Harvard School of Public Health, Boston
19. Thinh H. Tran, MD, Chief Medical and Quality Officer, Baptist Health South Florida, Miami
20. John Vassall II, MD, FACP, Chief Medical Officer, Swedish Medical Center, Seattle
21. Stephen Wallenhaupt, MD, Executive Vice President/Chief Medical Officer, Novant Health, Winston-Salem, N.C.

ABOUT VHA
VHA Inc., based in Irving, Texas, is a national network of not-for-profit health care organizations that work together to drive maximum savings in the supply chain arena, set new levels of clinical performance and identify and implement best practices to improve operational efficiency and clinical outcomes. Formed in 1977, through its 16 regional offices, VHA serves more than 1,400 hospitals and more than 25,500+ non-acute care providers nationwide. VHA was ranked by Modern Healthcare as the 7th best place to work in health care in 2009.

CLEVELAND, OH–(Marketwire – July 14, 2010) –  Relational Solutions announces the release of their new BlueSky Excel Builder. Life just got easier for Excel users with the BlueSky Excel Builder. BlueSky Excel Builder lets you create powerful spreadsheets from database queries quickly and easily. Users can mix and match data from multiple data sources using the dataset Wizard. This allows users to create queries without having to know anything about databases or the SQL language.

Pivot Tables made easy: BlueSky Excel Builder automatically pulls in the data and creates the Pivot Tables for you! Once data is in Excel, you simply use all the built in Excel features. Thus, there is no learning curve!

Distribute Excel Workbooks with security and data transparency: You can share Excel reports and report templates with other users simply by emailing it to them. If the user has the Excel Builder plug-in, they can update the report with a single mouse click and it will repopulate it with data relevant to their business area. Thus, Excel reports are updated with built-in security so that users get only what they are allowed to see providing total transparency to the business user.

Create Standardized Excel presentations: BlueSky Excel Builder is great for creating standardized Excel templates for Account Teams and casual users. Account Team members only need to click the “Refresh Data” button and the report will contain only the data they are entitled to see. It doesn’t get any easier!

Do you have PowerPoint Presentations linked to your Excel reports? Reports and charts linked from Excel to PowerPoint are also, repopulated when you click the “Refresh” button.

Integrated with Wal-mart RetailLink: User who want to directly populate their Excel reports with data they download from Walmart’s RetailLink, can now update their pre-designed Excel reports without the need to recreate their reports each time. This is because we have built our RetailLinker application right into our BlueSky Excel Builder. Wal-mart analysts can now easily update Wal-mart reports in Excel. Our Wal-mart Compliance Report and Request for Routing report can also be updated in three easy steps.

About Relational Solutions, Inc.
Based in Westlake, Ohio since 1996, RSI is a software and service company specializing in data integration and demand signal repositories for consumer goods companies. POSmart expedites the integration, cleansing and harmonization of point of sale data with syndicated, third-party and internal data, to improve retailer relationships, support customers better, streamline internal efficiencies, decrease OOS’s, and maximize profits. Applications include POSmart, POS Data Manager, BlueSky Analytics, BlueSky Forecaster, Promotion & New Item Tracking, RetailLinker, BlueSky ExcelBuilder and BlueSky Integration Studio (BIS).

Click here to see all recent news from this company

TORRANCE, CA–(Marketwire – July 14, 2010) –  Dr. Ramin Mirhashemi, MD, FACOG, of Gynecological Oncology Associates realized he needed to have an online presence and branding for his practice. With the help of Aurora Information Technology, his website GYNLA.com is the ultimate medical resource for his patients. Dr. Mirhashemi is an expert in robotic surgery, which he performs to treat gynecologic cancers including uterine, ovarian, cervical, and vaginal cancers, as well as fibroids, endometriosis, ovarian tumors and pelvic prolapse (robotic sacrocolpopexy, robotic hysterectomy and robotic myomectomy).

The domain name, GYNLA.com, was devised to encompass the practice and the region served. A fun and bright website design with an animated banner incorporating the fresh, new logo on the home page houses a wealth of information on topics in Dr. Mirhashemi’s overall gynecological expertise, including gynecologic oncology and robotic surgery. Mirhashemi developed techniques to perform these surgeries through robotic laparoscopic techniques. The robotic procedure is more accurate and minimally invasive, due to smaller incisions. Patients experience less pain and usually recover in about 1 week.

Dr. Mirhashemi, who has the largest experience in robotic surgery for gynecologic conditions “west of the Mississippi,” is a subject matter expert who has published over 60 journal articles, research articles and book chapters in regards to women’s health. Mirhashemi attended Medical School at the University of Southern California and completed his internship and residency at the Brigham and Women’s Hospital/Massachusetts General Hospital at Harvard Medical School. He received his fellowship in Gynecologic Oncology at the University of Miami. To his credit, he is a former Associate Professor of Obstetrics and Gynecology at the UCLA School of Medicine, and the University of Miami School of Medicine, as well as the Director of the Familial Breast and Ovarian Cancer Genetic Center at the University of Miami School of Medicine.

Because Dr. Mirhashemi is dedicated to improving women’s health via comprehensive gynecology, gynecologic oncology, and urogynecologic services, his mission for the website was to provide as much information as possible regarding the most common female medical conditions as well as treatment options. Mirhashemi believes in the efficiency of state-of-the-art robotic surgery in gynecology. “Because large abdominal incisions are not needed with the da Vinci robot that is used in robotic surgery, my patients recover much faster than with traditional open surgery, that requires these larger incisions,” explained Mirhashemi. “With robotic surgery, most of patients are discharged within 24 hours of their operations, with fewer complications.”

The site provides patient information such as physician/practice background, patient testimonials and hospital affiliations. In order to constantly improve the patient experience, the site features an online patient questionnaire that captures patient feedback on their experience with the practice. “My practice is patient-focused and their cure and satisfaction go hand-in-hand,” explained Dr. Mirhashemi. “If we’ve managed to do both successfully, and provide the value-add of medical information and education, then we’ve done our job well.”

Click here to see all recent news from this company

WAYNE, PA–(Marketwire – July 14, 2010) – Clinical and Laboratory Standards Institute (CLSI) recently published “Validation, Verification, and Quality Assurance of Automated Hematology Analyzers; Approved Standard–Second Edition” (H26-A2). This document covers portions of the life cycle of an automated multichannel hematology system and provides guidance for manufacturers’ validation, end-user laboratory verification, calibration, quality assurance (QA), and quality control (QC) through standardized approaches to ensure good science and clinical relevance.

Albert Rabinovitch, MD, PhD, NovoMetrics, Inc., and chairholder of the subcommittee that developed the document, says, “This new document applies the most current scientific and medically relevant approaches to assessment of automated hematology systems, replacing the shortfalls created by disparate individual sources. Beyond scientific presentation of theory, H26-A2 provides very detailed practical information (including appendices) on method evaluation that all readers will find useful. It serves as a model for clinical laboratory test systems in general, not just hematology.”

Historically, each complete blood count (CBC) instrument/reagent manufacturer developed its unique approaches to system validation and performance claims. This standard will help create better standardization among manufacturers, as well as assist practicing laboratories in developing consistent testing.

The intended audience includes manufacturers of such devices, end-user clinical laboratories, accrediting organizations, and regulatory bodies. End-user clinical laboratories will also find guidance for establishment of clinically reportable intervals (CRIs) and for QA for preexamination and examination aspects of their systems.

CLSI is a volunteer-driven, membership-supported, nonprofit organization dedicated to developing standards and guidelines for the health care and medical testing community through a consensus process that balances the perspectives of industry, government, and the health care professions. For additional information on CLSI, visit the CLSI website at www.clsi.org or call 610.688.0100.

Click here to see all recent news from this company

DENVER, CO–(Marketwire – July 14, 2010) –  Eating Recovery Center, a national eating disorders recovery program providing comprehensive treatment for anorexia and bulimia, today announced the opening of a new outpatient location. Enabling Eating Recovery Center to expand its outpatient recovery services, the new Denver, Colo. office will offer integrated care for eating disorders in a flexible outpatient setting. 

“This expansion allows Eating Recovery Center to offer patients a collaborative, team-based approach to outpatient eating disorder treatment,” said Kenneth L. Weiner, MD, CEDS, co-founder and medical director of Eating Recovery Center. “With access to a team of individual and family therapists, dietitians, and medical professionals, patients benefit from a well-rounded treatment experience that can help them achieve sustainable recovery.”

The outpatient clinical team works together to help individuals and families who are new to eating disorder treatment address disordered eating and body image issues before they have the chance to escalate. The clinicians are also committed to helping individuals who have been in a recovery program stay on track as they move into lower levels of care. The services offered include individual and family therapy, dietary counseling, psychiatric medical management, body image and aftercare eating disorder support groups, and an evening intensive outpatient program, which begins this month. 

The evening intensive outpatient program is an integrated option for individuals who require more structure than individual counseling provides. Participants meet Mondays, Wednesdays and Thursdays from 5 to 9 p.m. and take part in individual counseling, group therapy, nutrition education and multifamily therapy. They learn to break patterns that maintain their diseases and integrate sustainable changes into their lives. The timing of the program enables participants to integrate the skills learned in evening sessions into their daily lives.

“Eating disorders are complex conditions and every person’s experience with the disease is different,” explains Weiner. “The evening intensive outpatient program allows us to tailor treatment to the individual needs of each patient and promote successful recovery.” 

Eating Recovery Center also operates a licensed behavioral hospital for adults with severe eating disorders, and will open an adolescent treatment facility in the Denver Lowry neighborhood in October 2010. All services are guided by the leadership and clinical expertise of Weiner and Emmett R. Bishop, Jr., MD, CEDS, co-founders of Eating Recovery Center and nationally renowned experts who have separately founded numerous other eating disorder programs throughout the country.

The outpatient office is now open at 600 S. Cherry Street, Suite 600, in Denver, Colo. For more information or to make an appointment, please call 877-218-1344. 

About Eating Recovery Center
Eating Recovery Center is a national eating disorders recovery program, providing comprehensive treatment for anorexia and bulimia at the foot of the Rockies in beautiful downtown Denver, Colorado. Facilities include a licensed behavioral hospital treating adults, an outpatient office, and an adolescent facility scheduled to open in October 2010. Our integrated program offers patients from across the country a continuum of care that includes inpatient, residential, partial hospitalization, intensive outpatient and outpatient services. Our compassionate team of professionals collaborates with treating professionals and loved ones to cultivate lasting behavioral change. For more information please contact us at 877-218-1344 or [email protected] or confidentially chat live on our website.

Click here to see all recent news from this company

MIAMI, FL–(Marketwire – July 14, 2010) – Unity Management Group Inc. (PINKSHEETS: UYMG) is a Health Resource Company specializing in Physician and Hospital Practice Management, Medical Discount Plans, Business Services, Billing Software and Technologies.

UMGI is proud to announce that is has entered into a negotiation for an acquisition that will increase its revenue and assets.

Unity is in a due diligence stage of acquiring a healthcare related company. In the coming week we will be updating share holders with financials and corporate information of the target company.

UMGI management feel s that this can be a perfect fit and the company is fully funded.

The funding requirements for the acquisition have been obtained. Further information will be released in the next 7 business days.

Unity Management Group Inc. is also proud to announce that it has completed its disclosure statement, and legal opinion in respect that these are the listing documents that are necessary to obtain current status on the OTC markets. We foresee us receiving our PS status by Friday.

“We are proud to announce these extremely important current events. As previously mentioned this is a milestone for UMGI, and the company is working diligently to complete this acquisition, we will be announcing the outcome of these events within the next couple of business days. As always the company would like to thank its past present and future investors,” said Michael Oliver, Vice President.

For more information please goes to our website which can be found at www.unitymanagementgroup.com

Share structure:

100,000,000 million authorized

87,035,620 million issued and outstanding

43,439,460 million float

Unity Management Group, a health resource company, will continue to provide innovative physician practice management services that offer high value and significant return on investment for physicians’ practices and hospitals through its three subsidiary companies: United Healthcare Solutions Inc., Unity Technologies Inc., and United Business Services Inc.

The first subsidiary, Unity Business Services, is a full service management company offering solutions in practice management, billing, staffing, contracting, licensing, credentialing, and accounting. Unity Business Services also offers assistance in HIPPA compliance, marketing, and unique solutions for practice start-ups and new practices.

Unity Technologies Inc. is a complete software solutions company offering billing, electronic medical records, and electronic health records for physician’s offices and hospitals.

United Healthcare Solutions, a national company based in Nevada, is a healthcare company that will be providing medical, vision and dental discount plans, as well as PPO and HMO networks. 

The combination of these three subsidies provides unprecedented access to skilled leadership, managed care expertise, information systems, and economies of scale. Alex Berkovich, President of United Management Group, stated, “Through this merger, we are in a unique position to address the rapidly changing needs of the medical community. Business expertise is critical to the success of today’s physician offices and hospitals and we expect unpatrolled growth in the near future.”  

Certain information discussed in this press release may constitute forward-looking statements within the Private Securities Litigation Reform Act of 1995 and the federal securities laws. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions at the time made, it can give no assurance that its expectations will be achieved. Readers are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements are inherently subject to unpredictable and unanticipated risks, trends and uncertainties such as the Company’s inability to accurately forecast its operating results; the Company’s potential inability to achieve profitability or generate positive cash flow; the availability of financing; and other risks associated with the Company’s business. The Company assumes no obligation to update or supplement forward-looking statements that become untrue because of subsequent events.

TUSTIN, CA–(Marketwire – July 14, 2010) –  Radient Pharmaceuticals Corporation (NYSE Amex: RPC), a US-based pharmaceutical company, has announced the launch of its newly designed website located at www.radient-pharma.com and new corporate video featured on RPC’s new corporate website and recently launched Onko-Sure™ product website located at www.onkosure.com.

RPC’s new corporate website offers visitors ease of use and informative, comprehensive in-depth information on RPC’s company, management, products, and strategic plans. This site also provides a more comprehensive and informative investor relations section that will be of great interest to existing shareholders, prospective investors, the investment community in general, and the Company’s customers and strategic partners. Additionally, site visitors can now access more in-depth information on RPC’s corporate and product commercialization strategy, timeline and progress through RPC’s new corporate video which is accessible via www.radient-pharma.com and www.onkosure.com.

According to Douglas MacLellan, Chairman and CEO of Radient Pharmaceuticals, “Radient Pharmaceuticals is committed to providing and maintaining strong communication with our existing shareholders and prospective investors; the medical and healthcare community at large; and partners, suppliers, and customers. It is our expectation that with this new , informative and highly user-friendly design, RPC’s refreshed website will provide a more effective platform for the dissemination of news, updates, webcasts and pertinent shareholder and investor relations information concerning the company. As our company grows, we will continue to update our website with features and content that help our key audiences learn about what we do and the value we provide through our strong portfolio of cancer products, vaccines and therapies.”

Highlights of the newly designed RPC website include the following:

• Functional and Highly Intuitive Interface: RPC’s website was designed to provide ease of use, featuring a multi-level navigation that allows users to quickly access desired content.
• In-depth Investor Relations Section: includes investor highlights, RPC’s company history, and operations overview. In addition, this section offers RPC’s quote and data SEC filings, news releases, webcasts, analyst reports and information on the company’s strategic plans.
• Management: a listing of the company’s Directors and Executive Officers along with their respective bios and e-mail contacts.
• Product Portfolio and Associated Materials: A detailed overview of RPC’s product portfolio that includes clinical data and resources, regulatory and patent information, research and development initiatives, product innovations and relevant product news as it relates to our strategic plans and industry developments.
• Corporate Video: new video that provides in-depth details on RPC’s corporate and product commercialization strategy, timeline and progress.

Headquartered in Tustin, California, Radient Pharmaceuticals Corporation is a US-based pharmaceutical company specializing in the research, development and sales of In Vitro Diagnostic Cancer tests. The Company’s focus is on the discovery, development & commercialization of unique high?value diagnostic tests that help physicians answer important clinical questions related to early disease detection; treatment strategy; and the monitoring of disease progression, prognosis, and diagnosis to ultimately improve outcomes for patients. Our Onko?Sure™ IVD cancer test is used to guide decisions regarding patient treatment, which may include decisions to refer patients to specialists, perform additional testing, or assist in the selection of therapy. For additional information on RPC and its portfolio of cancer products visit the Company’s corporate website at www.Radient-Pharma.com. For Investor Relations information contact Kristine Szarkowitz at [email protected] or 1.206.310.5323.

About Radient Pharma:
Headquartered in Tustin, California, Radient Pharmaceuticals Corporation is an integrated pharmaceutical company devoted to the research, development, manufacturing, and marketing of diagnostic, and premium skin care products.

Forward Looking Statements:
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this document include certain predictions and projections that may be considered forward-looking statements under securities law. These statements involve a number of important risks and uncertainties that could cause actual results to differ materially including, but not limited to, the performance of joint venture partners, as well as other economic, competitive and technological factors involving the Company’s operations, markets, services, products, and prices. With respect to Radient Pharmaceuticals Corporation, except for the historical information contained herein, the matters discussed in this document are forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements.

Click here to see all recent news from this company

SKOKIE, IL–(Marketwire – July 14, 2010) –  According to Sg2, a future-focused health care information company, a hospital would need to reduce its direct costs by an average of $1,082 per case, or 14%, to sustain its current operating margins if average inpatient payments were paid at today’s Medicare rates. This finding comes on the heels of recent economic trends that indicate commercial payers may begin decreasing their reimbursement rates in the near term.

Sg2’s analysis suggests that providers must assume more accountability across the care continuum by improving clinical performance and significantly reducing costs to better manage to Medicare margins. With MedPAC projections of overall Medicare margins to be -5.9% in 2010 and performance-based penalties looming, the threat of commercial insurance reimbursement rates approaching Medicare levels in some markets adds tremendous financial pressure to health providers.

The number of Medicare patients will nearly double between 2005 and 2030 as the 78 million members of the Baby Boomer generation begin turning 65 in 2011. Additionally, tough economic conditions continue to make it increasingly difficult for employers to afford health insurance coverage, thereby placing more pressure on commercial payers to reduce premium costs. This, in turn, forces payers to reduce reimbursement rates to providers — rates that could eventually approach Medicare levels in some regions.

According to the Centers for Medicare & Medicaid Services (CMS), 40% of total Medicare spending is “waste” caused by issues including provider error, unnecessary care, avoidable admissions and lack of care coordination. This new playing field sets the stage for health providers to dramatically cut costs and improve clinical performance to meet market dynamics. One strategy that providers can implement is a disease-centered clinical approach that will help organizations identify the top Medicare severity diagnosis-related groups (MS-DRGs) with the highest cost reduction opportunities. Another effective measure is for hospitals to improve their level of clinical integration by assessing their performance across all inpatient and outpatient settings. This is effectively addressed through Sg2’s Systems of CARE™ (Clinical Alignment and Resource Effectiveness) methodology, which measures and monitors key health reform performance metrics such as potentially avoidable admissions and 30-day readmissions.

“This changing environment requires a radical shift in behavior. The onus firmly resides with the provider,” says Sg2 Chairman and CEO Michael Sachs. “The health care leader of the future must recognize incremental and long-term cost saving strategies today, while still delivering cost-effective, quality care. In order to survive and thrive, it is imperative for all organizations — regardless of size — to create a clinically integrated framework and understand financial implications of the growing Medicare population and performance-based incentives. Now is the time to implement a disease-centered approach that not only uncovers financial opportunities, but addresses clinical performance across both inpatient and outpatient settings.”

Sg2’s analysis is grounded in its Sg2 INSIGHT™ Clinical Performance Management System comparative database and the National Inpatient Sample (NIS). A hospital’s potential cost reduction exposure varies by market, provider type and size, with large community hospitals requiring the greatest percentage cost reduction at 17% to maintain overall operating margins at today’s Medicare reimbursement rates. For small- to medium-sized community hospitals, the average cost reduction is $849 per case and for academic medical centers it is $1,168 per case. Case mix, payer mix and relative payment levels drive the differences. For more information on this analysis, contact Sg2.

About Sg2
Sg2 is a health care information company that provides expert-led, future-focused systems for growth and clinical performance. Our advanced analytics, business intelligence, education and publications deliver measurable value across the full continuum of health care services. Sg2 works with more than 1,000 hospitals and health care organizations in the US and around the globe. For more information, visit www.sg2.com.

HOUSTON, TX–(Marketwire – July 14, 2010) –  Bederra Corporation (PINKSHEETS: BEDA) management has announced that it has submitted all necessary information to obtain Pink Sheets Current Information status and should obtain this status on otcmarkets.com within the next few days. This increased level of disclosure is intended to enhance shareholder transparency.

According to otcmarkets.com, “Companies that follow the International Reporting Standard or the Alternative Reporting Standard by making filings publicly available through the OTC Disclosure & News Service pursuant to Pink OTC Markets Guidelines for Providing Adequate Current Information are designated as Pink Sheets Current Information.” In its May 2010 OTC Market Snapshot, OTC Markets revealed that of 9,402 OTC companies, 1,237 were Pink Sheets Current Issuers. In May, trading in Pink Sheets Current Issuers accounted for more than 53% of the total trading dollar volume of OTC companies.

The company also announced that it has changed its Transfer Agent and has employed Transfer Online to streamline its securities management.

Management continues to seek additional acquisitions and diversification in an effort to bring long-term value to shareholders.

In the coming weeks the company will announce several actions that management believes will increase the long-term success of the company.

About Bederra Corp.
http://www.bederra.com
Bederra Corporation provides multiple modality diagnostic medical services to the greater Houston area and the world famous Texas Medical Center. The Company’s business strategy is to continue to expand its current operations and seek out additional acquisitions that will complement its core offerings.

Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company’s expectations with regard to the future impact on the company’s results from new products and services in development, including any planned acquisitions, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The results anticipated by any or all of these forward-looking statements might not occur. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company’s plans or expectations.

WICHITA, KS–(Marketwire – July 14, 2010) – Pulse Systems, Inc., an industry-leading vendor of ambulatory healthcare software solutions, announced that today’s finalization of stage one Meaningful Use measures will remove uncertainty from the market and unleash widespread adoption of effective electronic health record technology — such as Pulse EHR — while displacing substandard systems. “With more than 300 solutions currently calling themselves EHRs, we anticipate these rules will quickly whittle that list down to a few critical players,” said Senior Vice President Bruce Rowley.

Though the finalized measures were released today, the Pulse solution has been allowing users to meet Meaningful Use for months. The Pulse Patient Relationship Management version 4.1.02 was the first solution to become a fully CCHIT Certified® 2011 Ambulatory EHR, proving it allowed users to meet the previously proposed Meaningful Use measures. “From the very beginning, our development strategy has been aligned with the HHS vision, while most of our competitors seem to have been hoping for watered-down measures that would allow their systems to qualify,” said Senior Vice President of Healthcare Information Systems Chris Gregg. 

Gregg continued, “Pulse is unique in the marketplace as a company that built every aspect of its solutions by drawing from a single patient record and database, creating one of the only end-to-end, organic systems in existence,” he said. “Most of the ‘solutions’ offered by larger companies have been stitched together through acquisitions of separate systems over the last decade leading to fragile internal interfaces and limited cross-module access to data.”

Gregg also acknowledged that fulfilling stage one Meaningful Use requirements is not enough to ensure the future of an EHR. “Interoperability is paramount to future relevancy in the medical industry,” he said. “We support the open transaction of information, and we have demonstrated this through our use of standardized language and codified data. This helps us to be prepared for the measures we expect to see in stages two and three of Meaningful Use.”

CEO and President of Pulse Basil Hourani reiterated, “Pulse has been ready for these measures to become finalized so our clients can receive the maximum allowable ARRA stimulus payments. Pulse provides an easier way to meet the Meaningful Use guidelines and we are proud to be among the few solutions truly prepared to lead the healthcare industry into the next chapter in EHR technology.”

About Pulse Systems, Inc.
Pulse offers Electronic Health Records (EHR), Practice Management, ePrescribing and Revenue Cycle Management (Billing Services) used nationwide in more than 26 medical specialties. Pulse Practice Management and EHR products have both earned five star ratings from AC Group. Since 1982 Pulse has focused on its mission to develop, market and support healthcare practice workflow solutions that are easier to purchase, implement, utilize and upgrade. This focus on making things easier for clients is the key to a remarkable 95% client renewal rate. For more information, visit www.pulseinc.com.

Click here to see all recent news from this company

SAN FERNANDO, CA–(Marketwire – July 14, 2010) – Precision Dynamics Corporation, the global leader in healthcare identification solutions, announced today the release of the new Securline^® Bar Code Blood Band, a blood recipient ID wristband system that provides automated patient identification for blood transfusion, specimen collection, and tracking. As the only snap closure bar code blood band on the market, the product allows caregivers and phlebotomists to apply the band to patients quickly, correctly, and securely.

The Securline^® Bar Code Blood Band uses serialized bar code ID and alpha-numeric codes to accurately match the right patient to the right blood. This improves patient safety by reducing identification related human errors that can occur during the blood transfusion process. The product’s 12 matching bar code labels (four on the wristband and eight on the detachable tail that is applied to blood tubes) can be applied to additional draw tubes, patient chart, transfusion requisition, and as a secondary label on blood bags. A clear, adhesive shield on the wristband’s information area protects the patient ID labels and bar code from moisture or solvents for accurate bar code scanning. Soft, latex-free material maximizes patient comfort and safety yet is also durable and strong.

In contrast to the other leading bar coded blood wristband on the market, the Securline^® Bar Code Blood Band features an easy-to-use snap style closure and secure bar code labels, saving hospital staff valuable time and unnecessary frustration. Mary Ann Sharpe, Blood Bank Manager at Research Medical Center which belongs to HCA Midwest Health System, stated, “Securline^® Bar Code Blood Bands are easy to apply because the bands snap closed just like our admission wristbands. The other bar code blood bands we were using before were complicated and our staff struggled with putting the bands on patients. Plus, the bar code labels on the Securline^® product are very secure and don’t peel off accidentally like we experienced with the other band.”

“Bar coding continues to bring improvements in patient safety as hospitals adapt the technology to reduce human errors,” said Kim Canchola, Product Manager for Precision Dynamics. “The added bonus is the increase in productivity as hospitals use sheeted labels with bar codes instead of writing patient ID info by hand. The Securline^® Bar Code Blood Band combines the sophistication and functionality of bar coding for blood transfusions with the simplicity and comfort of a high quality, non-transferable identification wristband. The positive response we’ve received from our customers about their experience with this product is rewarding because we know we’re helping solve their problems by doing what we do best — delivering first-class identification solutions.”

The Securline^® Bar Code Blood Band meets current Joint Commission, AHA, and HIPAA requirements. For more information, please visit: www.pdcorp.com/healthcare or contact PDC’s Customer Care at 800-772-1122.

About Precision Dynamics Corporation:
The Leading Provider of Positive ID and Positive Outcomes™
With more than 50 years of experience, Precision Dynamics provides accurate, reliable, and easy-to-use healthcare ID solutions that empower the flawless delivery of care and enhance outcomes across all major hospital functions. Our products are used in all of the leading hospitals worldwide and comprise a comprehensive range of wristband and labeling systems that provide positive ID and positive clinical outcomes.

Precision Dynamics products meet important guidelines of The Joint Commission, World Healthcare Organization, FDA, AHA, and HIPAA. As the developer of the first single-piece patient wristband, the first bar code wristband system, and the first Smart Band® RFID wristband system, Precision Dynamics solutions are an integral part of some of the most successful patient safety initiatives. As an ISO 9001 certified company, Precision Dynamics follows a systematic, world-standard approach to ensure superior product design, manufacturing, and customer support services.

DUBLIN, IRELAND–(Marketwire – July 14, 2010) –   Trinity Biotech plc (NASDAQ: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter of 2010 on Thursday, July 29, 2010. The Company has scheduled a conference call for that same day, Thursday, July 29, 2010 at 11:00am EDT (4:00pm BST) to discuss the results of the quarter.

Interested parties can access the call by dialing:

A simultaneous webcast of the call can be accessed at: http://www.videonewswire.com/event.asp?id=70724

A replay of the call can be accessed until August 3, 2010 by dialing:

The webcast of the call will be available for 30 days at: http://www.videonewswire.com/event.asp?id=70724

About Trinity Biotech plc
Trinity Biotech develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and blood coagulation disorders, and to quantify the level of Hemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. Trinity Biotech sells direct in the United States, Germany, France and the U.K. and through a network of international distributors and strategic partners in over 75 countries worldwide. For further information please see the company’s website: http://www.trinitybiotech.com. 

Forward-looking statements in this release are made pursuant to the “safe harbor” provision of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties including, but not limited to, the results of research and development efforts, the effect of regulation by the United States Food and Drug Administration and other agencies, the impact of competitive products, product development commercialisation and technological difficulties, and other risks detailed in the Company’s periodic reports filed with the Securities and Exchange Commission.

ST. PAUL, MN–(Marketwire – July 14, 2010) –  HealthEast Care System is pleased to announce that Ann Schrader, Chief Operating Officer, has received two awards in the past two months for her significant contributions to Minnesota healthcare.

Schrader was named a 2010 Health Care Hero in Administrative Excellence by Twin Cities Business magazine and Medica. She was deemed one of eight of Minnesota’s outstanding contributors to the quality of health care in the state, selected from dozens of nominees for her time, focus, compassion, commitment, efforts, and imagination in delivering significant improvements in health care. Her drive to create a patient-centered experience, gold standard employee engagement, exceptional clinical outcomes, and dependable financial performance led to this honor.

Schrader, whose roots are as an RN caring for patients at the bedside, has spent the last 30 years as a senior leader at HealthEast. In 1986, she was instrumental in the merger of several St. Paul hospitals to create HealthEast Care System, the first successful unification of hospitals representing three Christian faiths in America. Schrader became HealthEast’s Chief Operating Officer in 1994. 

As operations leader, she was part of a team that brought about many firsts for HealthEast including:

• St. Joseph’s, St. John’s and Woodwinds were the first hospitals in Minnesota to perform surgeries live on the Internet.
• Bethesda Hospital became one of only two long-term acute care hospitals in the state.
• HealthEast launched an online prenatal education program, the first of its kind in the United States.
• HealthEast implemented a care navigation strategy that was the first of its kind in the Twin Cities.
• Woodwinds Health Campus officially opened in Woodbury; it was the first hospital of its kind to offer a unique environment blending integrative medicine, technology, customer service, and a healing nature for patients and their families.

Tim Hanson, HealthEast Care System Chief Executive Officer, credits Schrader for being an essential driver of best practices at all levels of the organization. “Her sense of integrity, honesty, innovation, and accountability have been at the foundation of HealthEast’s success,” said Hanson. “Her vision and strategic planning acumen have helped us respond effectively to a constantly changing industry.”

Schrader has also been selected by the Women’s Healthcare Leadership Trust to receive its Jean Harris Award. The Trust is a 30-year-old organization whose primary purpose is to support, educate, and promote women leaders in healthcare. Established in 2001, this award reflects the vision, integrity, and public leadership of Jean Harris, a physician and former mayor of Eden Prairie, who was known for making a difference in the health care of our communities.

Over the years, Schrader has given her time and talent as a board member to many organizations reflecting a broad spectrum of interests (ranging from business leadership to social services). In addition, she has served as a coach and mentor for many aspiring leaders at HealthEast as well as MHA and MBA students from the University of Minnesota, University of St. Thomas, St. Catherine University, and Mentiumm 100.

These awards celebrate Schrader’s innovative service and program contributions to HealthEast as well as her lifetime commitment to helping young healthcare professionals grow and develop their talents and competencies.

HealthEast Care System is a community-focused, non-profit health care organization that provides innovative technology, compassionate care and a full spectrum of family health services. HealthEast includes Bethesda Hospital, St. John’s Hospital, St. Joseph’s Hospital, and Woodwinds Health Campus as well as outpatient services, clinics, home care, and medical transportation services. Practicing financial responsibility, HealthEast is the largest, locally-owned health care organization in the Twin Cities’ East Metro with 7,300 employees, 1,200 volunteers and 1,400 physicians on staff.

BENSALEM, PA–(Marketwire – July 13, 2010) – Healthcare Services Group, Inc. (NASDAQ: HCSG)
reported that revenues for the three months ended June 30, 2010 increased
13% to $192,954,000 compared to $170,896,000 for the same 2009 period. Net
income for the three months ended June 30, 2010 increased 12% to $8,721,000
or $.20 per basic and per diluted common share, compared to the 2009 second
quarter net income of $7,815,000 or $.18 per basic and per diluted common
share.

Revenues for the six months ended June 30, 2010 increased 14% to
$376,755,000 compared to $331,305,000 for the same 2009 period. Net income
for the six months ended June 30, 2010 increased 4% to $16,149,000 or $.37
per basic and $.36 per diluted common share compared to the 2009 six month
period net income of $15,551,000 or $.36 per basic and $.35 per diluted
common share.

The Board of Directors has declared a second quarter 2010 regular quarterly
cash dividend of $.23 per common share, payable on August 6, 2010 to
shareholders of record at the close of business July 23, 2010. This
represents a 5% increase over the dividend declared for the 2010 first
quarter and a 21% increase over the 2009 same period payment. It is the
29th consecutive regular quarterly cash dividend payment, as well as the
28th consecutive increase since our initiation of regular quarterly cash
dividend payments in 2003.

The Company will host a conference call on July 14, 2010 at 8:30 AM Eastern
Time to discuss its results for the three and six month periods ended June
30, 2010. The call in numbers are 800-401-3551 and 913-312-0688 (passcode #
2084962).

Cautionary Statement Regarding Forward-Looking Statements

This release and any schedules incorporated by reference into this report
contain forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934 (the “Exchange Act”), as amended, are not historical
facts but rather based on current expectations, estimates and projections
about our business and industry, our beliefs and assumptions. Words such as
“believes,” “anticipates,” “plans,” “expects,” “will,” “goal,” and similar
expressions are intended to identify forward-looking statements. The
inclusion of forward-looking statements should not be regarded as a
representation by us that any of our plans will be achieved. We undertake
no obligation to publicly update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise. Such
forward-looking information is also subject to various risks and
uncertainties. Such risks and uncertainties include, but are not limited
to, risks arising from our providing services exclusively to the health
care industry, primarily providers of long-term care; credit and collection
risks associated with this industry; one client accounting for
approximately 11% of revenues in the six month period ended June 30, 2010;
risks associated with our acquisition of Contract Environmental Services,
Inc. including integration risks and costs, or such business not achieving
expected financial results or synergies or failure to otherwise perform as
expected; our claims experience related to workers’ compensation and
general liability insurance; the effects of changes in, or interpretations
of laws and regulations governing the industry, our workforce and services
provided, including state and local regulations pertaining to the
taxability of our services; and the risk factors described in our Form 10-K
filed with the Securities and Exchange Commission for the year ended
December 31, 2009 in Part I thereof under “Government Regulation of
Clients,” “Competition” and “Service Agreements/Collections,” and under
Item IA “Risk Factors.” Many of our clients’ revenues are highly contingent
on Medicare and Medicaid reimbursement funding rates, which Congress has
affected through the enactment of a number of major laws during the past
decade, most recently the March 2010 enactment of the Patient Protection
and Affordable Care Act and the Health Care and Education Reconciliation
Act of 2010. Currently, the U.S. Congress is considering changes or
revising legislation to reform health care in the United States which,
among other initiatives, may impose cost containment measures impacting our
clients. These laws and proposed laws have significantly altered, or
threatened to alter, overall government reimbursement funding rates and
mechanisms. The overall effect of these laws and trends in the long-term
care industry have affected and could adversely affect the liquidity of our
clients, resulting in their inability to make payments to us on agreed upon
payment terms. These factors, in addition to delays in payments from
clients, have resulted in, and could continue to result in, significant
additional bad debts in the near future. Additionally, our operating
results would be adversely affected if unexpected increases in the costs
of labor and labor related costs, materials, supplies and equipment used in
performing services could not be passed on to our clients.

In addition, we believe that to improve our financial performance we must
continue to obtain service agreements with new clients, provide new
services to existing clients, achieve modest price increases on current
service agreements with existing clients and maintain internal cost
reduction strategies at our various operational levels. Furthermore, we
believe that our ability to sustain the internal development of managerial
personnel is an important factor impacting future operating results and
successfully executing projected growth strategies.

Healthcare Services Group, Inc. is the largest national provider of
professional housekeeping, laundry and dietary services to long-term care
and related facilities.

                     HEALTHCARE SERVICES GROUP, INC.
               CONDENSED CONSOLIDATED STATEMENTS OF INCOME
                               (Unaudited)

                                               For the Three Months Ended
                                                        June 30,
                                                  2010           2009
                                              -------------  --------------
Revenues                                      $ 192,954,000  $  170,896,000
Operating costs and expenses:
   Cost of services provided                    165,240,000     145,830,000
   Selling, general and administrative           13,150,000      13,516,000
                                              -------------  --------------
Income from operations                           14,564,000      11,550,000
Other income (loss):
    Investment and interest income (loss)          (383,000)      1,157,000
                                              -------------  --------------
Income before income taxes                       14,181,000      12,707,000
Income taxes                                      5,460,000       4,892,000
                                              -------------  --------------
Net income                                    $   8,721,000  $    7,815,000
                                              =============  ==============

Basic earnings per common share               $         .20  $          .18
                                              =============  ==============

Diluted earnings per common share             $         .20  $          .18
                                              =============  ==============

Cash dividends per common share               $         .22  $          .18
                                              =============  ==============
Basic weighted average number of common shares
 outstanding                                     43,965,000      43,537,000
                                              =============  ==============

Diluted weighted average number of common
 shares outstanding                              44,652,000      44,262,000
                                              =============  ==============




                     HEALTHCARE SERVICES GROUP, INC.
               CONDENSED CONSOLIDATED STATEMENTS OF INCOME
                               (Unaudited)

                                                 For the Six Months Ended
                                                         June 30,
                                                    2010          2009
                                                ------------- -------------
Revenues                                        $ 376,755,000 $ 331,305,000
Operating costs and expenses:
   Cost of services provided                      323,812,000   283,722,000
   Selling, general and administrative             27,051,000    24,392,000
                                                ------------- -------------
Income from operations                             25,892,000    23,191,000
Other income:
    Investment and interest income                    366,000     2,094,000
                                                ------------- -------------
Income before income taxes                         26,258,000    25,285,000
Income taxes                                       10,109,000     9,734,000
                                                ------------- -------------
Net income                                      $  16,149,000 $  15,551,000
                                                ============= =============

Basic earnings per common share                 $         .37 $         .36
                                                ============= =============

Diluted earnings per common share               $         .36 $         .35
                                                ============= =============

Cash dividends per common share                 $         .43 $         .35
                                                ============= =============
Basic weighted average number of common shares
 outstanding                                       43,932,000    43,497,000
                                                ============= =============

Diluted weighted average number of common shares
 outstanding                                       44,655,000    44,168,000
                                                ============= =============




                      HEALTHCARE SERVICES GROUP, INC.

                  CONDENSED CONSOLIDATED BALANCE SHEETS
                                (Unaudited)

                                                               December 31,
                                                June 30, 2010      2009
                                                ------------- -------------
Cash and cash equivalents                       $  34,968,000 $  31,301,000
Marketable securities, net                         44,099,000    52,648,000
Accounts receivable, net                          107,253,000   104,356,000
Other current assets                               23,715,000    23,865,000
                                                ------------- -------------
  Total current assets                            210,035,000   212,170,000

Property and equipment, net                         4,931,000     4,391,000
Notes receivable- long term, net                    6,165,000     4,623,000
Goodwill , net                                     16,955,000    17,087,000
Other Intangible Assets, net                        8,198,000     8,862,000
Deferred compensation funding                      11,238,000    10,783,000
Other assets                                        9,032,000     7,976,000
                                                ------------- -------------

Total Assets                                    $ 266,554,000 $ 265,892,000
                                                ============= =============


Accrued insurance claims- current               $   5,305,000 $   4,844,000
Other current liabilities                          27,237,000    29,873,000
                                                ------------- -------------
  Total current liabilities                        32,542,000    34,717,000

Accrued insurance claims- long term                12,377,000    11,302,000
Deferred compensation liability                    11,479,000    11,099,000
Stockholders' equity                              210,156,000   208,774,000
                                                ------------- -------------

Total Liabilities and Stockholders' Equity      $ 266,554,000 $ 265,892,000
                                                ============= =============

ORLANDO, FL–(Marketwire – July 13, 2010) –  WellCity, Inc. (http://www.wellcity.com), a wellness-related social network and subsidiary of WellTek, Inc. (OTCBB: WTKN), today unveiled WellCity Market^™, its network marketing platform, calling all consumers and network marketers to be one of the first to join this ground-breaking opportunity to create optimum health and long-term wealth by getting social inside WellCity.

“Until now, social network users have had no way to leverage their personal network as a direct income opportunity. Today, we’ve changed that,” said David George, CEO of WellCity. “We are the first social network to offer actual money to its users. With the integration of WellCity Market, our WellCity ‘residents’ have an unprecedented opportunity to help others achieve optimal health, while they earn income from the purchases made by their network of family and friends or ‘neighbors.’ It’s a simple idea: users get paid every time their ‘neighbors’ make a purchase inside WellCity Market.”

WellCity Market offers a breadth of natural products to help others live a more enriched life physically, spiritually and financially. The technology of online social networking provides the single most effective medium today for creating long-term wealth and for teaching people about new products and services that help people feel better, lose weight, prevent disease and become younger and stronger even as people grow older.

According to world-renowned economist Paul Zane Pilzer, the emerging Wellness Industry has quickly become the hottest trend in the world today and it is predicted to reach $1 trillion by 2012. Furthermore, according to Direct Selling News, well over $70 billion dollars in revenue was generated in 2009 by the top 100 network marketing companies. “The convergence of the Wellness Industry with Network Marketing and Social Networking provides an extraordinary opportunity for our residents in WellCity, as well our shareholders; we are creating the perfect storm of opportunity,” said Randy Lubinsky, Chairman and CEO of WellTek. “It’s comparable to merging Amway with Facebook.”

About WellCity Incorporated
WellCity is a social utility where health- and wellness-minded ‘residents’ can closely commune with one another; receive support, information and encouragement from their ‘neighbors’ and from a league of leading professional experts; shop for health and wellness-oriented product and services; compete in WellCity’s proprietary 90-Day Wellness Challenge; and even enjoy income opportunities by leveraging their personal network. For more information on the Company, please visit www.WellCity.com.

About WellTek Incorporated
WellTek is a global health, fitness and wellness company that provides proven solutions to help address some of the world’s most pressing and costly health and wellness challenges. The Company owns and operates WellCity, Inc., a premiere wellness-related social utility that helps ‘residents’ live happier, healthier, longer lives. The Company’s subsidiary, MedX Limited, manufactures, markets and distributes the most advanced medical exercise equipment to the medical and fitness markets. Through its wholly owned subsidiary Pure HealthyBack, Inc., WellTek is redefining healthcare delivery by providing health plans, self-insured employer groups, and consumers with a viable non-surgical, lower cost treatment for patients who are seeking lasting relief from chronic neck and back pain. For more information on the Company, please visit www.WellTekinc.com. 

Certain statements contained in this press release, which are not based on historical facts, are forward-looking statements as the term is defined in the Private Securities Litigation Reform Act of 1995, and are subject to substantial uncertainties and risks in part detailed in the respective Company’s Securities and Exchange Commission filings, that may cause actual results to materially differ from projections. Although the Company believes that its expectations are reasonable assumptions within the bounds of its knowledge of its businesses, expectations, representations and operations, there can be no assurance that actual results will not differ materially from their expectations. Important factors currently known to management that could cause actual results to differ materially from those in forward-looking statements include the Company’s ability to execute properly its business model, to raise additional capital to implement its continuing business model, the ability to attract and retain personnel — including highly qualified executives, management and operational personnel, ability to negotiate favorable future debt facilities and capital raises, and the inherent risk associated with a diversified business to achieve and maintain positive cash flow and net profitability. In light of these risks and uncertainties, there can be no assurance that the forward-looking information contained in this press release will, in fact, occur. 

NEW YORK, NY–(Marketwire – July 13, 2010) – Maimonides Medical Center Urologist Dr. Ridwan Shabsigh, director of the Division of Urology, created his “Ask The Doctor” medical advice talk show to help bridge the gap of men’s healthcare information in a simple-to-understand format. His online health talk show, “The Dr. Ridwan Show” delivers accurate and usable health information on common men’s health questions.

Along with an elite panel of experts, Drs. Harry Fisch, Michael Perelman and Richard Sadovsky, the group provides reliable health information to common men’s health questions. Ridwan and his medical panelists provide unique insights and advice that support the show’s tagline, “Health information you can use.” The panelists discuss a hot topic per episode in men’s health such as heart disease, prostate cancer, testosterone deficiency and erectile dysfunction.

Each episode of Dr. Ridwan’s unique online doctor consultation show concludes with helpful action tools that incite viewers to take positive actions for their health. The most helpful action tool is a men’s health calculator. This health risk calculator helps to raise awareness and motivate men to access health care services and pursue healthier lifestyles.

This men’s health calculator is not an absolute measure of risk or a substitute for professional health advice, but it helps men to assess their risk of having hypertension (high blood pressure), hyperlipidemia (high cholesterol), diabetes and/or coronary artery disease. The viewer can answer basic questions on health status, erectile dysfunction, relationships, and waist size to help determine health risk.

Other helpful tips provided on Dr. Ridwan’s doctor advice show:

• Avoid abdominal obesity to prevent heart and vascular disease risk
• Men’s health preventive ideas
• Get annual checkup and prostate screenings
• Ask for urologist referral if abnormal urinary symptoms exist
• Men should work with partners to improve health
• Review health risks and reduce these factors
• Watch for sexual problems
• Be aware of testosterone deficiency symptoms

By providing answers to medical questions online, Dr. Ridwan hopes to reduce the need for unnecessary procedures and tests. “In these times of healthcare reform, by educating my viewers, I hope to make them be more proactive in monitoring their health,” said Ridwan. “This way they won’t have to make unnecessary trips to the emergency room for something that can be taken care of in advance or prevented.”

Click here to see all recent news from this company

IRVING, TX–(Marketwire – July 13, 2010) –  Redlands Community Hospital, a 205-bed facility located in Southern California, has joined VHA Inc., the national health care network and business cooperative that serves 1,400 not-for-profit hospitals across the nation. Redlands wants to enhance its ability to network with other providers in the region to develop solutions to challenges they all face, such as how to enhance clinical quality in the face of dwindling resources. 

“Most hospitals and health systems are drawn to VHA because of its supply chain management services, but that wasn’t a primary motivator for us,” said Jim Holmes, president and chief executive officer at RCH, which purchases about $25 million in supplies annually. “The health care marketplace is an increasingly challenging environment, and we determined that it would be best for RCH to be part of a larger network of hospitals, without giving up our local control. VHA provides that opportunity.”

The CEO of another VHA member hospital in California, Jim West at Presbyterian Intercommunity Hospital in Whittier, actually sold Holmes on VHA. “I explained that being a member of VHA connects our organization to thought leaders and solutions that we need to improve performance. Being a member of VHA creates leverage and gives us clout we don’t have on our own. I think that discussion made the decision to join VHA easier for Redlands,” said West.

In addition to joining VHA’s national network, RCH is also joining VHA’s regional network, VHA West Coast, which links more than 90 hospitals in Arizona, California, Hawaii, Nevada and one hospital in both Oregon and Washington. Through VHA, these organizations leverage their knowledge, purchasing clout and other resources to help each other improve.

“VHA creates connections and energy that enable hospitals to accelerate their performance,” said Rick Barnett, senior vice president of VHA’s West Coast office, located in Pleasanton, Calif. “We’re excited about having RCH in the VHA family. We’ve pursued the organization for two years, and we believe RCH will benefit through its membership, and it will deliver benefits to other members as the RCH team interacts with VHA peers.” 

About VHA

Based in Irving, Texas, VHA is a national network of not-for-profit health care organizations that work together to drive maximum savings in the supply chain arena, set new levels of clinical performance and identify and implement best practices to improve operational efficiency and clinical outcomes. Formed in 1977, through its 16 regional offices, VHA serves more than 1,400 hospitals and more than 28,000 non-acute care providers nationwide. VHA was ranked by Modern Healthcare as the 7th best place to work in health care in 2009.

SAN DIEGO, CA–(Marketwire – July 13, 2010) –  International Stem Cell Institute (ISCI, www.iStemCelli.com) announced today the launch of highly effective Stem Cell Therapy treatments aimed at providing a better quality of life for those suffering with Cerebral Palsy (CP).

Details are available at www.iStemCelli.com/cerebralpalsy.html or calling 800-609-7795.

ISCI Executive Director Rita Alexander maintains, “Every parent wants their child to live a happy, healthy life as a baby, as a toddler, as a first grader. CP is a tremendously overwhelming condition — it’s really hard to understand the daily frustrations parents go through when a child is diagnosed with CP. And while the condition can’t be completely cured, our stem cell treatment is dramatically improving the quality of life for many children, much beyond their parent’s expectations. The results are truly amazing.”

Cerebral Palsy is not a disease like chicken pox or measles. It is an umbrella term for a group of related disorders stemming from different causes. The condition seriously affects muscle movement, and is caused by abnormalities in the brain. One million children in the US are afflicted with CP, and more will be diagnosed as we see an increase in the survival of premature infants and multiple births.

According to Alexander, CP is often associated with injury in the womb or during birth, and especially evident in premature infants. Alexander notes, “The earlier we can treat an infant or child with Stem Cell Therapy the greater the positive impacts on their future development.” She continues, “We’re working with very young children and infants. Stem Cell Therapy is a very gentle treatment, it’s gentle enough for a six month old baby.”

The procedure — safely and comfortably administering placental stem cells into several key parts of the body — is a leading-edge alternative CP treatment proving highly effective for infants and even older children afflicted with CP. Alexander relates, “The good thing is parents don’t have to wait for the new developments in this field, the procedure is available right now and affordable for most families.”

Stem cell therapy has been shown to relieve a wide variety of CP symptoms. Alexander claims, “We’re treating children with a variety of symptoms, like the lack of muscle coordination, those who have stiff and tight muscles or floppy muscles, children with exaggerated reflexes and children dragging one foot or walking on their toes.”

ISCI’s Stem Cell Therapy treatments are also being hailed as a potent medical tool in treating the seizures, difficulty with vision, hearing and speech, incontinence, and recurring lung infections that children can often experience with CP.

ISCI’s CP patient advocate, LeiMomi Ferrill, has personally seen impressive results with stem cell therapy in CP patients. “You’re heart really goes out to these parents and children. When a parent tells us their child can now roll over, or talk or balance a bit, they’re walking through a door where they feel there is hope for the very first time. We have one child, William, who was practically comatose and unable to communicate. He’s now telling his Mother he loves her, knows and calls his brothers by name, and is talking with his family about what he likes to eat.”

Alternative treatments currently being explored for CP include electrical stimulation — pulsing electricity into the motor nerves — and hyperbaric oxygen therapy in which high concentrations of oxygen are forced into brain tissues under pressure. Researchers at the University of Georgia are conducting the first ever FDA approved stem cell clinical trials for brain injuries. Dr. James Carroll, chief of pediatric neurology at the MCG School of Medicine, claims, “Stem cell therapies using cord blood have been used successfully for more than 20 years, but here we have a study which is breaking new ground in advancing therapies for brain injury.”

ISCI strongly supports scientific research on CP, especially the work of the Cerebral Palsy International Research Foundation (CPIRF), the leading nongovernmental organization funding advanced research in CP.

Patients and families with Cerebral Palsy are encouraged to learn about treatments by calling the International Stem Cell Institute at 800-609-7795 or online at www.istemcelli.com/cerebralpalsy.html.

About ISCI (www.iStemCelli.com)
ISCI is an innovator in stem cell therapy and regenerative medicine dedicated to providing a pathway to treatments which may improve health and quality of life for thousands of people with degenerative diseases around the world. Over 3,000 patients have safely undergone stem cell treatments. The company accepts patients globally, and is dedicated to the highest medical and ethical standards.

Disclaimer: Stem Cell Therapies offered for consideration by International Stem Cell Institute are not currently approved by the FDA and the treatments and procedures mentioned take place outside the USA. Stem Cell Treatments are not a cure for any condition, disease or injury, nor a substitute for proper medical diagnosis and care. The information contained in this press release and ISCI’s written materials should not be considered medical advice. It is intended to be used for educational and information purposes only.

MUNDELEIN, IL–(Marketwire – July 13, 2010) – Medline Industries, Inc., the nation’s largest privately held manufacturer and distributor of healthcare supplies, today announced the winners of its inaugural 2009 Preferred Vendor Recognition Awards. Selected by a panel of executives from Medline’s Preferred HealthCare Division, the Preferred Vendor Awards were given to four Medline partners who not only demonstrated outstanding performance in sales and operations but also have collaborated as a true partner in Medline’s initiatives and in achieving mutual goals.

The following companies were honored at Medline’s 2010 National Meeting and Sales Conference in Montgomery, TX:

• Rookie Vendor of the Year: SunTech Medical (Morrisville, NC) was recognized for their support and sales growth of the SunTech 247 vital signs device since Medline launched the product in May 2009. 
• Vendor of the Year: Abbott Diabetes Care (Alameda, CA) was honored as the Vendor of the year who demonstrated a strong commitment to sales and marketing, as well as operational and supply chain excellence.
• Sales Merit Award: Abbott Nutritional (Columbus, OH), and Caltech Industries (Midland, MI) were both recognized for showing outstanding sales growth over the prior year while maintaining key economic initiatives.

“Our partnership with vendors is an essential element of our success with our customers,” said Maroun Abouzeid, president of Preferred HealthCare. “We thank all our partners for their contributions and congratulate our award-winning partners for their ongoing leadership.”

About Medline Industries, Inc.
Medline, the nation’s largest privately held manufacturer and distributor of healthcare products, manufactures and distributes more than 100,000 products to hospitals, extended-care facilities, surgery centers, home care dealers and agencies. Headquartered in Mundelein, Ill, Medline has more than 800 dedicated sales representatives nationwide to support its broad product line and cost management services.

Over the past five years, Medline has been the fastest-growing distributor of medical and surgical supplies in the U.S., serving as the primary distributor to over 450 major hospitals and healthcare systems. As a leading distributor, Medline offers a comprehensive array of consulting and management services encompassing the supply chain and logistics, utilization and standardization, business tools and enhanced reporting capabilities and on-staff clinicians.

Medline has a growing network of 34 distribution centers around the country, as well as an expanding, dedicated transportation fleet with over 180 vehicles in a variety of sizes to fit customers’ specific delivery needs. The fleet is equipped with the latest navigation devices for enhanced order tracking and communication. 

NEW YORK, NY–(Marketwire – July 13, 2010) –  The Patient Channel, a 24/7 in-hospital television network from Interactivation Health Networks, has conducted a study for one if its pharmaceutical advertisers that demonstrates above average ROI — a 5:1 ROI after six months and 8:1 ROI after a 12 month targeted advertising campaign — further evidence of the immense value of Digital Out-of-Home advertising, particularly as it relates to hospitals as a “fourth screen” location. 

“The reason why advertising is so effective at hospital bedside, and why the Patient Channel and Newborn Channel work is simple — we provide marketers with a unique and differentiated platform that offers compelling and essential health content delivered at the precise moment it is needed most,” said Suzanne Fleming, SVP of Sales at Interactivation Health Networks. “Our channels provide the ideal branding environment where consumers are highly attentive, highly motivated and ready to act. Connecting brands with our hyper-focused audience is an opportunity that is hard to replicate with traditional television advertising.”

Interactivation Health Networks engaged IMS Consulting to perform a quantitative ROI study based upon dispensed prescribing tied to participating physicians exposed to a specified pharmaceutical company’s program. The study found that when comparing post-exposure prescribing to a similar control group of physicians, identified by IMS, the pharmaceutical company saw a +2.1% incremental increase in prescribing, representing a positive return on the pharmaceutical company’s investment with Interactivation Health Networks.

Results from the IMS study corroborate findings from studies conducted by Nielsen* and Razorfish** that project the continued rise of Out-Of-Home advertising due to the unchallenged ability to pinpoint a targeted, and often captive, audience with relevant messaging. For brands within the health and wellness field, the Interactivation Health Networks are a documented means of successfully activating these consumers.

Advertisers who use The Patient and Newborn Channels will have the added opportunity of further engaging with their target audience via Interactivation’s propriety interactive technology. This would allow viewers of ads to directly and immediately interact with the brand with their mobile device to receive more information or coupons on the advertised product. For example, consumers can locate a nearby retailer by texting their zip code to the Interactivation-owned short code promoted in their on-air commercial.

About Interactivation Health Networks
The Patient Channel and The Newborn Channel are the most comprehensive in-hospital TV networks. Delivered directly to patient rooms and waiting areas, the Channels provide viewers with original, award-winning health programs and advertisers with the unique ability to integrate brand messaging with content that is compelling and endorsed by healthcare professionals. The Newborn Channel broadcasts baby care and postpartum programming for new parents, reaching 60% of new moms. The Patient Channel features both condition-specific and preventative health programming to empower and inform patients. The channels are currently available in over 2,700 hospitals nationwide.

IMS Health Consulting conducted the study with one of the Patient Channel’s long-standing advertisers.

*Nielsen Inaugural Fourth Screen Report – April 12, 2010
**Razorfish Outlook Report 2010

NEW YORK, NY–(Marketwire – July 13, 2010) –  Healthnostics, Inc. (PINKSHEETS: HNSS), a medical and biotechnology analytics company, has completed its acquisition of Worldwide Wipes Co., “a U.S. manufacturer and distributor of wipes for medical, veterinary, disinfecting, and a variety of other uses, and the company’s market ranges from cartons for individuals to truckloads for corporations. The Company places a priority on price, quality, and convenience, providing prompt, free shipping.”

Terms of the acquisition include net profit benchmarks of $300,000 to $600,000 in the first year and $600,000 to $900,000 in the second year.

“We are pleased to announce the completion of the most important event in our Company’s history. The Worldwide Wipes price points are exceptionally competitive, and its customer base is nationwide. Following several years of base-building, this acquisition represents such a quantum leap for Healthnostics that we are contemplating a name and stock symbol change that reflects the diversified nature and direction of the Company,” said President Alan Grofe.

About Healthnostics

Healthnostics, Inc. is a medical and biotechnology analytics company that provides comprehensive patient clinical monitoring and risk management systems to acute care hospitals and utilizes its Internet portals to deliver medical and biotechnology resource information to industry professionals as well as to the general public. Healthnostics’ major products include: Worldwide Wipes Co., a manufacturer and distributor of medical and other wipes, MedGuardian, a patient care monitoring and risk management system for hospitals that is fully Web-based; and through the MedBioWeb subsidiary, MedBioWorld™, one of the largest professional medical and biotechnology directory resource and reference portal sites on the Internet, and FamilyMedicalNet, a companion consumer healthcare information portal.

For further information please visit Healthnostics www.healthnostics.com, and Worldwide Wipes Co. www.wipesco.com, MedBioWorld www.medbioworld.com, and FamilyMedicalNet www.familymedicalnet.com.

And visit us on Facebook at www.facebook.com/Healthnostics.

This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management’s current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.

MILWAUKEE, WI–(Marketwire – July 13, 2010) –  CPI has released a new company logo and website. The new crisisprevention.com consolidates all CPI websites, including preparetraining.com, dementiacarespecialists.com, and iancici.org, into a single enhanced and redesigned site.

Based on customer and Certified Instructor feedback, crisisprevention.com is completely revamped to include more intuitive navigation, improved account management, and an enhanced online shopping experience. It also includes a new documentation feature, which allows Certified Instructors to submit training documentation online.

The company logo has been redesigned to reflect the CPI mission and values. The logo shows people reaching out to each other with their hands, symbolizing the integral relationship between CPI and its Certified Instructors in their mission to educate, empower, and enrich the lives of others. Individual logos for each CPI specialized offering — Nonviolent Crisis Intervention^® training, Prepare Training^® program, and Dementia Care Specialists — have also been updated with a fresh, coordinated look.

According to Tony Jace, CPI chief executive officer, the new logos and website mirror the company’s commitments to expand the message of care and well-being.

“We value our commitment to increase the effectiveness of our Certified Instructors as they manage their day-to-day interactions and responsibilities. Through our new look and improved tools, we continue to provide individuals and organizations the resources they need to create safer, enriched environments,” he said.

CPI, headquartered in Milwaukee, WI, is the world’s leading training organization specializing in the safe management of disruptive and assaultive behavior. CPI’s cornerstone Nonviolent Crisis Intervention^® training and Prepare Training® programs focus on workplace violence prevention and offer effective strategies for managing anxious, hostile, or violent behavior. Through Dementia Care Specialists, CPI also offers dementia care training to improve function, safety, and quality of life. Since 1980, more than 6 million professionals have participated in CPI training, and thousands of organizations worldwide have successfully implemented CPI’s unique behavior management techniques.

AKRON, OH–(Marketwire – July 13, 2010) –  Hospitals can gain significant revenue by improving documentation of services and procedures and instituting better material management practices.

That’s the counsel from Ryerson Healthcare Consultants, medical revenue specialists and the nation’s leader in emergency department process improvement. The Ryerson organization serves clients with hospital charge capture experience gained through working with more than 540 hospitals in 40 states.

Whether they are working on clients’ surgical services or emergency department charge capture, Ryerson’s experts tailor improvement recommendations to fit each hospital’s specific challenges.

“OR and ED operations are uniquely complex, and staff in both areas tend to experience problems in properly documenting, coding and billing for all chargeable procedures and supplies,” said President Peter Ryerson. “Our team of hospital charge capture specialists includes people who have considerable experience as RNs in both areas, with track records of success in successfully improving their client hospitals’ revenues.”

Such experience and knowledge is invaluable for hospital charge capture improvement, the goal for the majority of Ryerson Healthcare Consultants’ clients. Ryerson said his team develops solutions that result in improvements to the charge protocol and hospital charge capture process.

“In many, if not most, cases, it comes down to strengthening our clients’ documentation and billing processes,” Ryerson said. “We find that many hospitals lack the tools and information necessary to properly document, code and bill. The obvious result is billing that fails to capture all of the services that are rendered.”

He said refining the documentation and charge processes and training managers and staff in the proper procedures can result in significant gains in both OR and ED charge capture. In many cases, such gains can transform a money-losing surgical services or emergency department into a reliable profit center. 

Ryerson’s team also works on strengthening material management procedures. Relying on time-proven protocols, Ryerson develops best-practice material management processes and helps its client hospitals institute them. Ryerson also guides training of staff and managers in the value of remaining in compliance with the procedures.

“We also find that improving communication between the financial managers and the clinical staff pays great dividends,” he said. “When the financial people and clinicians understand each other’s roles in achieving profitability, we see time after time that this enhances the hospital’s ability to effectively cost and bill for provided services.”

Click here to see all recent news from this company

CHARLOTTE, NC–(Marketwire – July 13, 2010) –  Patient Care Technology Systems (PCTS), a subsidiary of Consulier Engineering, Inc. (NASDAQ: CSLR), today announced that Providence Willamette Falls Medical Center will add Amelior ORTracker® — a web-based workflow visibility and automation solution built to streamline patient flow and improve efficiency — in their Oregon City, OR Surgical Services Department. 

Providence Willamette Falls Medical Center is a 143-bed healthcare facility serving the Portland area since 1954. In October 2009, Willamette Falls Hospital officially became Providence Willamette Falls Medical Center when it joined the Providence Health and Services family.

The installation, expected to be complete by the fourth quarter 2010, will include the solution Amelior ORTracker — part of the Amelior Enterprise Visibility and Workflow Automation Suite™ which comprises department to facility-wide software solutions and services designed to more efficiently and safely orchestrate patient care through the real-time visualization of patient flow. Hospitals can scale their implementations by the entities they wish to track (patients, staff, movable medical equipment), purpose (patient flow, temperature monitoring, asset management, infection control) and by the scope of hospital workflow (surgical services, acute care, inpatient floors, outpatient services, enterprise-wide).

With the Amelior ORTracker system, Providence Willamette Falls can monitor, in real-time, the status of patients as they travel through the perioperative process from pre-op, inter-op, PACU (post anesthesia care unit) and post-op. They will have access to computer watch lists that will provide a comprehensive view of the cases for the day, including real-time patient and staff status and location. 

Providence Willamette Falls will join its “sister” facilities Providence Portland Medical Center and Providence St. Vincent Medical Center, which have been using Amelior ORTracker since 2003. In the last seven years, these facilities have seen a reduced time waiting between stages of care in a perioperative visit, enabling them to add-on cases and effectively increase departmental capacity; provided a quieter, more healing environment by decreasing the need for overhead pages and phone calls; and improved safety through the automatic tracking of key intervals such as the administration of antibiotics.

“It’s Providence’s goal to continue to provide the best care possible in all the communities we serve. This includes providing a consistent platform for patient and staff satisfaction,” said Deborah Tuke Bahlman, Providence Health & Services – Oregon Regional IT Director of Surgical Services. 

Tony Marsico, president and chief executive officer for PCTS says, “We have a long history of partnering with Providence, and we welcome the opportunity to implement Amelior ORTracker in another PH&S facility. Providence again shows their continued dedication to their community.”

PCTS has expanded their Amelior Enterprise Visibility and Workflow Automation Suite into other departments within the Providence Health and Services community in Oregon, including the Providence Heart and Vascular Institute and the radiology department at Providence St. Vincent.

About Providence Willamette Falls Medical Center
Providence Willamette Falls Medical Center is a not-for-profit acute care hospital operated by Providence Health & Services in Oregon City, OR. Established in 1954 as Doctors’ Hospital, the hospital moved to its current location in 1961 and has 143 licensed beds at its 243,000-square-foot (22,600 m²) facility. Providence Willamette Falls also operates several medical offices and clinics outside of Oregon City in other parts of Clackamas County. Previously known as Willamette Falls Hospital, the hospital merged with Providence in 2009.

About Patient Care Technology Systems
Patient Care Technology Systems, a subsidiary of Consulier Engineering, Inc. (NASDAQ: CSLR), helps health care providers to improve patient flow, increase capacity and improve patient and staff safety by visualizing the real-time location and status of people and equipment throughout their facility. PCTS solutions have supported over 2 million patient visits annually and have shown a proven return on investment in high turnover, high-acuity units such as the emergency department and perioperative suites. The Amelior Enterprise Visibility and Workflow Automation Suite™ is interoperable with all leading locating technologies, including active-RFID, infrared, ultrasound, ultra-wideband, Wi-Fi and ZigBee. PCTS customers have been recognized nationally for improvements in efficiency and clinical excellence. For more information, visit www.pcts.com. 

This press release contains forward-looking statements within the meaning of federal securities laws. PCTS and CSLR caution you that any statements contained in this press release which are not strictly historical statements constitute forward-looking statements. Such forward-looking statements include, but are not limited to, those related to PCTS’s and CSLR’s expectations regarding continued business growth. These statements are neither promises nor guarantees, and involve risks and uncertainties that could cause actual results to differ materially from such forward-looking statements, (copies of which may be obtained at the SEC’s website at: http://www.sec.gov) — could impact the forward-looking statements contained in this press release. Readers should not place undue reliance on any such forward-looking statements, which speak only as of the date they are made. PCTS and CSLR disclaim any obligation to publicly update or revise any such statements to reflect any change in PCTS and CSLR’s expectations, or in events, conditions or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements.

Click here to see all recent news from this company

ANDOVER, MA–(Marketwire – July 13, 2010) –  Capsule, the leading provider of medical device connectivity, announced that they will be hosting a webinar on July 21, 2010 at 1:00pm Eastern Time on a number of issues hospitals are facing in reaching meaningful use criteria outlined in the HITECH provision of the ARRA. Featured in the webinar will be how medical device integration improves patient care and safety and helps meet Phase I, II and III meaningful use criteria including CPOE.

Ann Farrell, Principal at Farrell Associates, and Kevin Phillips, Partner Development Manager at Capsule, will engage in an interactive discussion about medical device integration and meaningful use. They will discuss why it is critical that real time data be available when hospitals are implementing CPOE technology. They will also discuss how medical device integration can affect the entire enterprise and help meet a number of patient care and safety goals and why it therefore should be placed on a hospital’s short term priority list.

Key topics that will be discussed include: the real benefits of medical device integration, how device integration can recover nursing hours, how can it improve overall patient care and safety, how it addresses hospitals’ key issues surrounding clinical workflow and CPOE, and how device integration can help meet Phases 1, 2 and 3 meaningful use criteria as outlined in the HITECH provision of the ARRA. The speakers are also encouraging participants to submit individual questions prior to the webinar by filling out a form on the registration page. For more information and to register and submit your questions right away click here: https://www1.gotomeeting.com/register/614983312

About Capsule’s Enterprise Device Connectivity Solution™
Capsule’s Enterprise Device Connectivity Solution is the only solution that will truly adapt to the environment it operates in. Its design gives hospitals the option to deploy connectivity throughout the enterprise so that all departments, not just high acuity, can enjoy the value that device integration has to offer. And it completely integrates with existing or planned caregiver work processes and allows a facility to leverage existing technologies. For more information about Capsule’s Enterprise Device Connectivity Solution, visit http://www.capsuletech.com.

About the Capsule Neuron™ platform
The Capsule Neuron is Capsule’s Next Generation Bedside Platform for managing device connectivity. It is a touch screen device equipped with its own docking station that provides a universal view and status of connectivity for all devices connected to a patient, including devices that are connected locally to a Capsule Neuron docking station and devices that are networked via the hospitals’ wired or wireless LAN. And the Capsule Neuron provides the basis for an expanding set of solutions to enable positive patient association, improved bedside workflow and enhanced patient safety. For more information about the Capsule Neuron visit http://www.capsuletech.com/our-solution-capsule-neuron.htm.

About Capsule
For more than 12 years, Capsule has been the world’s leading, award-winning provider of solutions for medical device connectivity. The company has established market leadership through its FDA 510(k) cleared software and medical grade hardware products, its unique expertise in device protocols and firmware, and through its strong partnerships with major medical device manufacturers and HIS companies. Capsule’s solutions are proven, with over 617 installations at leading healthcare facilities worldwide and its technology is secure, with the largest installed device driver library. Furthermore, Capsule is continually recognized as the leader in the industry receiving the Frost & Sullivan Global Technology Leadership Award as well as the Deloitte Technology Fast 50 and Fast 500 EMEA Awards. And, with the introduction of the Capsule Neuron™ platform and Enterprise Connectivity Solution, Capsule will continue to be the leader, by working with our partners to develop and implement solutions that meet the short and long term patient safety needs of hospitals today. For more information about Capsule, visit the company’s Web site at http://www.capsuletech.com/ or contact the U.S. Marketing & Public Relations department at 978-482-2337.

Click here to see all recent news from this company

ROCKVILLE, MD–(Marketwire – July 13, 2010) –  MarketResearch.com has announced the addition of GBI Research’s new report “Surgical Equipment Market to 2016 – Emerging Economies to Provide Future Growth Opportunities,” to their collection of Surgical Equipment market reports. For more information, visit http://www.marketresearch.com/product/display.asp?ProductID=2718784.

GBI Research’s medical equipment report, “Surgical Equipment Market to 2016 – Emerging Economies to Provide Future Growth Opportunities” provides key data, information and analysis on the global surgical equipment market. This report on medical technologies provides data on market landscape, competitive landscape and market trends information on three surgical equipment market categories — Electrosurgical Devices, Hand Instruments and Surgical Sutures. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

The global surgical equipment market has grown steadily during the last decade due to an increase in the number of hospitals and the rise in the number of surgical procedures performed both in the developed and emerging economies. In the future, the number of surgical procedures performed in the emerging economies is expected to grow at a faster rate than in developed economies, due to the higher economic growth forecasts for the emerging economies.

The surgical equipment market is highly competitive and fragmented with a healthy mix of international and local players. The addition of new hospitals and an increase in the number of operating rooms in existing hospitals in the emerging economies provide growth opportunities for both established players and new entrants.

Topics covered in the report include…

• Key geographies covered include the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
• Market size and company share data for three surgical equipment market categories – Electrosurgical Devices, Hand Instruments and Surgical Sutures.
• Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company share data for 2009.
• Qualitative analysis of key market trends, market drivers, and restraints by each category within the surgical equipment market.
• The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
• Key players covered include Ethicon, Covidien, B. Braun, ERBE Elektromedizin, CONMED Corporation and Integra LifeSciences.

For more information, visit http://www.marketresearch.com/product/display.asp?ProductID=2718784.

Click here to see all recent news from this company

ALEXANDRIA, VA–(Marketwire – July 13, 2010) –  Summer means gardening, grilling, and swimming at the pool. Summer’s produce and expanded cooking options also mean the season is an opportunity to improve your eating habits. The American Diabetes Association announced today a completely revised online nutrition tool in English and Spanish to help you get ready for the season: MyFoodAdvisor™ (www.diabetes.org/MyFoodAdvisor).

The award-winning MyFoodAdvisor has new and expanded features that allow people to track their daily meals, substitute healthier alternatives in recipes or on the plate, and browse recipes. People with diabetes, heart disease, kidney disease, high blood pressure, high cholesterol and those looking to lose weight can use MyFoodAdvisor to find nutrition information on calories, carbohydrates, sodium, fat and cholesterol.

“You would be surprised to see how small substitutions at meal time can make a real difference in your health,” commented Christine Tobin, CDE, President, Health Care & Education, American Diabetes Association. “MyFoodAdvisor can set you up for success by showing you healthy alternatives, tracking what you eat and helping create goals. Losing 10 or 15 pounds can help stop diabetes by preventing or delaying type 2 diabetes or diabetes complications.”

Join American Diabetes Association’s Director of Nutrition and Clinical Affairs Stephanie Dunbar, MPH, RD, and USA Today’s Medical Reporter Mary Brophy Marcus to discuss healthy eating and using the completely revised MyFoodAdvisor during a Twitter Chat on Thursday, July 15, at 2 p.m. ET, at @AmDiabetesChat and #ADA_USAT.

New features include:

• Track It – You can create your own goals for calories, carbohydrate, sodium, saturated fat and fiber and compare what you currently are eating to what you want to be eating. This analysis allows you to make healthier options to lower sodium or saturated fat intake or to keep your carbohydrate intake consistent from day to day.
• Spanish Version – The entire web site is now available in Spanish. The prevalence of diabetes is 2 to 4 times higher among Hispanics/Latinos.

Updated features include:

• Healthy Alternative – This feature, unique to MyFoodAdvisor™, allows you to search for healthier foods. For example, searching for a healthier alternative to ground beef for your favorite burger recipe would provide choices for other ground meat products like turkey or even vegetable-based meat alternatives. The algorithm, based on recent research, takes into account 13 different nutrients to recommend the best alternatives based on your selections.
• Recipe Analysis – Analyze your favorite recipes with our Create Dish functionality. You can request healthier options for all of your recipe ingredients to make your old favorite a healthier favorite. Your own recipes can be saved in your recipe box and imported into the tracking it tool, and ingredients added to a shopping list.
• Create Dish – The portion sizes have been expanded to meet your preferences for using simple cooking measurements.
• Simpler Navigation – The new version allows you to better search and compare food options.

“For people with diabetes and their caregivers, one of MyFoodAdvisor’s useful features remains that serving sizes are based on 15 grams of carbohydrate, which makes it easier to count carbs. There is also information on phosphorus and potassium, two important nutrients to watch for people with kidney disease,” commented Tobin. “But MyFoodAdvisor can help anyone looking to make smart food choices this summer.”

The American Diabetes Association is leading the fight to stop diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, our mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.

id=”nav_links”>

ALEXANDRIA, VA–(Marketwire – July 13, 2010) – Prepararse para el verano significa sembrar
los jardines, limpiar el asador y salir a comprar trajes de baño. Los
productos del verano y las opciones para cocinar también significan que la
temporada es una oportunidad para mejorar sus hábitos alimenticios. La
Asociación Americana de la Diabetes anunció hoy sobre una herramienta en
línea de nutrición en español y en inglés que le ayudará a prepararse para
la temporada.: MiConsejerodeComida™ http://tracker.diabetes.org/es/.

MiConsejerodeComida tiene características nuevas y mejoradas que le
permitirán a las personas a mantener un registro de sus comidas diarias,
sustituir alternativas más saludables para recetas o en el plato. Las
personas con diabetes, enfermedades cardiacas, enfermedad renal, alta
presión arterial, alto colesterol y aquellas personas que quieren bajar de
peso pueden utilizar MiConsejerodeComida para encontrar información
nutricional sobre calorías, carbohidratos, sodio, grasa y colesterol.

“Hacer pequeños cambios al tiempo de la comida puede tener un impacto
positivo en su salud,” comentó Lorena Drago, RD, CDE, voluntaria de la
Asociación Americana de la Diabetes. “MiConsejerodeComida le puede enseñar
hacer alternativas saludables, crear metas y registrar lo que come. Si
pierde solamente 10 o 15 libras, usted puede ponerle alto a la diabetes al
prevenir o retrasar la diabetes tipo 2 o sus complicaciones…”

Las características nuevas incluyen:

• Versión en español – Todo el sitio web está disponible ahora en
  español. La prevalencia de la diabetes es de 2 a 4 veces más alta entre
  los hispanos/latinos.
• Regístrelo – Usted puede crear sus metas para calorías,
  carbohidratos, sodio, grasa saturada y fibra y compararlas con lo que
  actualmente está comiendo y lo que quisiera comer. Este análisis le permite
  hacer opciones más saludables para reducir el consume de sodio y grasa
  saturada o para mantener su consumo de carbohidratos consecuente en el día
  a día.

Las características actualizadas incluyen:

• Alternativa saludable – Esta característica, exclusiva a
  MiConsejerodeComida™, le permite buscar comidas más saludables. Por
  ejemplo, si busca una alternativa más saludable para la carne de res
  molida para su receta favorita de hamburguesa, le proporcionaría otras
  opciones de carne molida tales como, pavo molido o alternativas
  vegetarianas. El algoritmo, que es basado en investigaciones recientes,
  toma en cuenta 13 nutrientes diferentes para recomendar la mejor
  alternativa basándose en sus selecciones.
• Análisis de recetas – Analice sus recetas favoritas con nuestra
  función de Crear un plato. Usted puede solicitar opciones más saludables
  para los ingredientes de su receta para hacer que un viejo favorito sea un
  favorito saludable. Sus propias recetas pueden ser guardadas en su
  recetario e importadas a la herramienta de registro y los ingredientes
  pueden ser agregados a su lista de compras.
• Crear un plato – Los tamaños de las porciones han sido
  incrementadas para reunir sus preferencias al utilizar medidas simples de
  cocina.
• Navegación simple – Esto le permite buscar y comparar opciones
  de comidas con más facilidad.

“Los tamaños de las porciones en MiConsejerodeComida son basadas en 15
gramos de carbohidratos, lo cual hace que sea más fácil para las personas
con diabetes y sus cuidadores a contar carbohidratos. MiConsejerodeComida
también tiene información sobre fósforo y potasio, 2 nutrientes importantes
que se deben vigilar para las personas con enfermedad renal, comentó Lorena
Drago. “Sin importar para qué, MiConsejerodeComida puede ayudar a cualquier
persona a prepararse para el verano al enseñarle como hacer mejores
opciones de comida.”

La Asociación Americana de la Diabetes es líder en la lucha para ponerle
alto a la diabetes y sus consecuencias fatales y lucha por las personas
afectadas por esa enfermedad. La Asociación financia la investigación a fin
de prevenir, curar y controlar la diabetes; ofrece servicios para cientos
de comunidades; suministra información objetiva y verosímil; y da voz a
aquellas personas privadas de sus derechos como consecuencia de la
diabetes. La Asociación se fundó en 1940. Nuestra misión es prevenir y
curar la diabetes, así como mejorar la vida de todas las personas afectadas
por esa enfermedad. Para más información llamar al 1-800-DIABETES
(342-2383) o visitar www.portufamilia.org. Información sobre ambas fuentes
se encuentra disponible en inglés o en español.

SALT LAKE CITY, UT–(Marketwire – July 13, 2010) –  AdvancedMD® Software, Inc., the leader in all-in-one, web-based practice management, Electronic Health Record (EHR), and billing applications for medical practices and medical billing services, today announced that Physicians Resource Network, Inc. (PRN) became an AdvancedMD billing partner in March, and achieved AdvancedBiller™ status in July, by adding 17 providers to the AdvancedMD platform within a four month period, with six of those providers on the AdvancedMD EHR clinical package.

PRN, using the automated, integrated AdvancedMD Software-as-a-Service (SaaS) platform, is able to eliminate manual processes between the client practice and the PRN billing center, enabling the company to reduce staff required to service a client practice by approximately 30 to 60 percent. “With AdvancedMD as our foundation,” said Frances Holinda, president of Physicians Resource Network, “we are able to offer our clients a complete solution to deliver everything they need to stay current under healthcare reform. It’s all there, whether it’s online charges, integrated EHR or automated reporting, we can accommodate virtually any need. AdvancedMD is our power tool, enabling me to consult with our clients and maximize their revenue.”

PRN, founded in 1993, is based in Ocean, N.J. The company supports 25 providers who practice primarily in nephrology, cardiology and various surgery practices. The firm offers a range of practice services, including demographics data entry, charge entry, charge submission, payment posting, secondary insurance claims submission, appeals follow up, patient statements and patient follow up. “We pretty much handle everything up to the point of sending out collection letters,” said Holinda, who has an MBA in Health Care Management and is a member of HBMA. “I had enough experience in billing to know what I needed and to know that what I saw in AdvancedMD was exactly what I needed.”

Previously Holinda ran her business on a Unix-based, client/server platform, located on her premises. Many of the processes she has been able to automate using AdvancedMD were manual processes under the older system. In order for her clients to link to the Unix system, they had to install complicated VPNs. Additionally, someone on her staff was responsible for managing regular data backups. “Comparing what my office could provide in terms of redundancy, automated backups and bandwidth into the data center, to what AdvancedMD can provide, my business simply could not make the kind of IT investments that AdvancedMD has made in its enterprise class data center,” she added.

Since her business is physician billing, the main concern Holinda had when selecting a new billing platform were the revenue cycle management tools. “The EHR capabilities were a bonus,” said Holinda. “The fact that the EHR is so good means I can offer that clinical product to my physicians with confidence. Plus, if they prefer a different EHR, AdvancedMD gives me the option of interfacing to external products. I have all the tools I need to do their billing. The physicians have choices!”

Bill Stone, vice president and general manager of the AdvancedMD Billing Services Program, said: “Physicians Resource Network is an excellent example of the kind of experienced, proven billing service company that the AdvancedBiller program is attracting. Not only does our technology enable these seasoned business managers to become more efficient in servicing their client base, the platform offers a range of clinical and front office tools that make the practice more efficient. As a vendor that does not compete with our billing services partners, AdvancedMD is wholly focused on helping our AdvancedBiller partners grow and become more profitable.”

Resources:

• For additional background on Physicians Resource Network, read the case study.

• For more information about the AdvancedBiller program, visit www.advancedbiller.com.

About Physicians Resource Network, Inc.

PRN, founded in 1993, is based in Ocean, N.J. The company supports 25 providers who practice primarily in nephrology, cardiology and various surgery practices. The firm offers a range of practice services, including demographics data entry, charge entry, charge submission, payment posting, secondary insurance claims submission, appeals follow up, patient statements and patient follow up. For more information, visit: http://www.saasmedicalbilling.com/

About AdvancedMD Software
AdvancedMD provides a market leading Software-as-a-Service (SaaS) electronic health record (EHR) and practice management (PM) software platform delivered to more than 10,000 providers and 300 medical billing service providers nationwide. As a complete Medical Practice Optimization solution, the product combines the clinical with the financial to improve workflow and revenue capture. The AdvancedMD solution includes a certified EHR, patient portal, scheduling, electronic eligibility verification, electronic prescribing, and mobile access capabilities for the practice, and sophisticated, efficient claims processing, denial tracking and revenue management for the billing professional. Processing more than 1M claims per month through its clearinghouse, the company is able to identify payer rule changes quickly and continuously adjust the software to reflect those changes, yielding first-pass claim acceptance rates of 95 percent or better, compared to the national average of 70 percent. For more information, please visit www.advancedmd.com.

TAMARAC, FL–(Marketwire – July 13, 2010) –  AcuMedSpa Holdings, Inc. (PINKSHEETS: AMSZ), a provider of Medical Aesthetic, Spa and Acupuncture services, announced it has entered into talks to make two separate acquisitions. One of the companies is domestic and the other international.

The domestic acquisition has a substantial nationwide footprint which when completed will open up several new markets for AcuMedSpa. The international acquisition is progressing well but is slightly behind the domestic one in terms of expected timeframe for finalization. When completed, it will provide AcuMedSpa with a global presence in the spa industry.

The company is also making headway with its project to open AcuMedSpa in Poland. Completion will take a little longer due to some of the legal aspects and complexities involved in dealing with the E.U.

The previous sale of the company’s “Spa within a Practice” subsidiary in the month of May, has cleared nearly half a million dollars in debt off the books and will allow AcuMedSpa to realize positive earnings in 2010. When originally stating its revenue and earnings expectations for the current year, the company took into consideration its pending acquisitions, incorporated with its current business activities. Upon completion of these two key acquisitions the company expects to meet and exceed its previously stated 2010 projections.

“Over the past few months we have been working very hard to successfully improve current operations while reducing our liabilities,” stated AcuMedSpa Holdings President Gregory Antoine. “Our objective all along has been to expand our business two ways. First through the successful acquisition of spa and aesthetic practices, and second by opening new facilities in key markets.” Mr. Antoine further commented, “Our progress so far this year together with these acquisitions nearing completion puts us on pace to exceed our $2,000,000 net income goal for 2010.”

The company also announced that its wholesale health and beauty division, Consumer Care of America LLC, is on pace to exceed expectations. The focus of this division is high volume sales. More detailed information on Consumer Care of America will be provided in a future update.

Please follow our progress on twitter: http://twitter.com/acumedinc

For additional info please visit our website: http://www.acumedspa.com/

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements as a result of various factors, and other risks. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and AcuMedSpa Holdings, Inc. takes no obligation to update such statements.

ALEXANDRIA, VA–(Marketwire – July 12, 2010) –  Over the past several weeks reports have again surfaced regarding the cardiovascular safety of the diabetes drug rosiglitazone. While some analyses have suggested an increased cardiovascular risk with use of rosiglitazone, others have not provided any evidence of such an association. To help patients and physicians make informed decisions regarding use of rosiglitazone, the American Association of Clinical Endocrinologists (AACE), the American Diabetes Association and The Endocrine Society issued a joint statement with recommendations:
http://www.diabetes.org/for-media/2010/ada_aace_endo.html

The statement recommends that patients should continue taking all currently prescribed medications unless instructed otherwise by their health care provider. Stopping diabetes medications can result in higher levels of blood glucose that may cause serious short term health problems and could increase the risk of diabetes-related complications in the long term.

The joint statement also informs patients that regardless of the opinion and decisions on rosiglitazone, there are numerous drugs available to maintain glucose control in people with type 2 diabetes. Patients should discuss these options with their health care providers.

In the next few days (July 13-14) the U.S. Food and Drug Administration (FDA) is expected to complete the Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee. This committee was convened to evaluate the scientific research available on the safety of rosiglitazone and then issue its decision on how the drug should or should not be used. The joint statement recommends that until further clarification is provided by the FDA, the decision whether or not to use any medication must remain that of the treating provider in direct discussion with the individual patient.

Following any decision from the FDA, AACE, the American Diabetes Association and The Endocrine Society will provide detailed information interpreting FDA action for both health care professionals and patients with diabetes.

The American Diabetes Association is leading the fight to stop diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, our mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.

Founded in 1916, The Endocrine Society is the world’s oldest, largest and most active organization devoted to research on hormones and the clinical practice of endocrinology. Today, The Endocrine Society’s membership consists of over 14,000 scientists, physicians, educators, nurses and students in more than 100 countries. Society members represent all basic, applied, and clinical interests in endocrinology. The Endocrine Society is based in Chevy Chase, Maryland. To learn more about the Society and the field of endocrinology, visit our site at www.endo-society.org.

AACE is a professional medical organization with more than 6,000 members in the United States and 91 other countries. AACE members are physicians who specialize in endocrinology, diabetes, and metabolism. For more information about AACE, visit our Web site at www.aace.com, become a fan on Facebook at www.facebook.com/theaace or follow us on Twitter at www.twitter.com/theaace.

id=”nav_links”>

WINCHESTER, CA–(Marketwire – July 12, 2010) –  Michael Cooper is a Vietnam veteran from Tampa, Florida. Having served in the U.S. Army from 1970-73 as a helicopter flight engineer, Cooper saw more than his share of combat. “My father was a WWII Army veteran so the decision to serve my country came easily,” says Cooper. He also knows firsthand what it’s like to be hospitalized, adding, “It’s the boredom that’s the worst. All the free time you have between appointments is the hardest to deal with.” Cooper recalls coming out of surgery and the first thing he was asked was if he would like to assemble a craft kit. The individual offering the kit was a Craft Care Specialist (CCS), employed by national nonprofit Help Hospitalized Veterans (HHV) and stationed at the Tampa VA medical center.

As a patient, Cooper went on to enjoy working with many of the arts & crafts provided by HHV and later decided to volunteer in the craft clinic. His help with HHV craft kits has now come full-circle, as Cooper himself is now employed as the CCS at the Tampa VA Medical Center. “I never dreamed I’d have this job. It’s such a joy to be of service to other veterans. It’s particularly rewarding to help those who are feeling down. Every day I get to witness new sparks of life. For some veterans, work on the arts and crafts brings about improvement of fine and gross motor skills, while others enjoy increased attention spans. Cognitive improvements have even been seen in brain injury patients. Every week somebody’s life is changed,” adds Cooper. “We utilize the HHV kits throughout the hospital and favorites include model cars and motorcycles, leather and sun catchers.”

“Perhaps the most intriguing benefit the arts & crafts provide is the impact they’re having in the pain care clinic,” said Cooper. “You wouldn’t believe it, but people with significant pain find their tolerance level increases while working on the arts & crafts. It’s as if the diversion tricks the brain and for that period of time the patient is able to find relief and comfort.”

HHV is the largest supplier of free therapeutic arts and crafts kits to our nation’s VA and military hospitals. Since the organization was founded in 1971, over 25 million therapeutic arts and crafts kits have been donated to hospitalized veterans absolutely free of charge with over $3.5 million worth donated to the Tampa VA medical center since their inception to the program.

For more information on HHV programs and services please visit www.hhv.org or call toll-free 1-888-567-VETS.

Documents and/or Photos available for this release:
PDF_of_release

To view supporting documents and/or photos, go to www.enr-corp.com/pressroom and enter Release ID: 263241

MUNDELEIN, IL–(Marketwire – July 12, 2010) –  Only 40 percent of infection control professionals indicated that more than three-quarters of the nurses at their facility were applying the CDC’s CAUTI prevention guidelines, and less than half reported that their facilities were conducting annual education and training on alternatives to catheterization, according to a survey conducted today. The survey of infection control professionals was conducted at a breakfast forum on prevention of catheter-associated urinary tract infections (CAUTI), sponsored by Medline Industries, Inc. in conjunction with the Association for Professionals in Infection Control and Epidemiology (APIC) Annual Scientific Meeting being held in New Orleans, LA. 

Additionally, while nearly 80 percent of attendees cited CAUTI prevention as one of their facility’s top priorities this year, almost half reported that they do not have an annual competency validation process for staff to assure that they are competent in CAUTI prevention measures and inserting Foley catheters.

“These results reaffirm the need for industry vendors to partner with healthcare providers on a comprehensive system that incorporates proper procedures and social behaviors that are easy to adopt in everyday practice,” said Lorri Downs, R.N., B.S.N., M.S., C.I.C., vice president of Infection Prevention at Medline and a board certified infection preventionist. “Reducing CAUTI rates is not just about taking precautions. We must transfer knowledge to the bedside clinician in new ways such as through interactive learning and online competency validation courses to ensure industry guidelines become the standard course of care.”

That was the experience at Arkansas Methodist Medical Center, located in Paragould, AR. The organization did not have a formal education program in CAUTI prevention prior to implementing Medline’s ERASE CAUTI program, but has seen significant results since it began using the evidence-based program three months ago.

“Since we’ve been using the ERASE CAUTI program, our facility has experienced an almost 20 percent decrease in our CAUTI rate and a more than 10 percent decrease in the number of Foley catheters placed,” said Lisa Bridges, infection preventionist at Arkansas Methodist Medical Center. “I believe the decreases will be even more in the coming months. We are still in the process of educating our staff on following the guidelines. Having the checklist on the outer packaging helps us to make sure that catheterization is an appropriate option for the patient.”

Medline is highlighting evidence-based CAUTI prevention practices and products at this year’s APIC Congress (booth #1907). During the three-day exhibition, Medline is demonstrating its ERASE CAUTI program, a revolutionary new approach to managing catheters and reducing CAUTI. Based on the same criteria the CDC used in developing their new CAUTI prevention guidelines, the ground-breaking ERASE CAUTI program features a reengineered one-layered catheter tray coupled with an evidence-based clinical education program.

As part of its presentation, the Medline clinical team is conducting a series of live, multimedia overviews of its cutting edge competency validation tools for assessing and sustaining staff results. The interactive competency programs are available to staff anytime via Medline University, Medline’s online education resource, and can be easily incorporated into the annual skills competency program for a facility’s nursing staff.

CAUTI is one of the most common healthcare-associated infections, not only comprising 40 percent of all institutionally acquired infections, but also eight percent of infections in the home care setting. Studies show that one in four patients receives an indwelling urinary catheter at some point during their hospital stay and up to 50 percent of these catheters are placed unnecessarily.

Additional information on the ERASE CAUTI program is available on Medline’s website at www.medline.com/erase.

About Medline Industries, Inc. 
Medline, the nation’s largest privately held manufacturer and distributor of healthcare products, manufactures and distributes more than 100,000 products to hospitals, extended-care facilities, surgery centers, home care dealers and agencies. Headquartered in Mundelein, Ill., Medline has more than 900 dedicated sales representatives nationwide to support its broad product line and cost management services.

Over the past five years, Medline has been the fastest-growing distributor of medical and surgical supplies in the U.S., serving as the primary distributor to over 450 major hospitals and healthcare systems. As a leading distributor, Medline offers a comprehensive array of consulting and management services encompassing the supply chain and logistics, utilization and standardization, business tools and enhanced reporting capabilities and on-staff clinicians.

SILVER SPRING, MD–(Marketwire – July 12, 2010) –  The Association of Public Health Laboratories (APHL) has received an award for $16.3 million from the Centers for Disease Control and Prevention (CDC) to enhance the work of public health laboratories in the US and abroad. The award continues an APHL-CDC collaboration of over 20 years in support of governmental health laboratories.

Funded as a five-year cooperative agreement, the award will assist APHL to promote quality public health laboratory practice, strengthen the public health laboratory system and develop a well-trained workforce. 

“APHL is committed to improving health outcomes by strengthening the capacity of public health laboratories both nationally and globally,” said Dr. Patrick Luedtke, director of the Unified State Laboratories in Utah and APHL president. “Public health laboratories protect us against diseases, environmental hazards, natural disasters and other health threats. A stronger lab system means healthier people.”

APHL is a leader in development and implementation of public health laboratory practice, systems, policy and training. Members serve as laboratory first responders, protecting the public from diseases and environmental health hazards. 

The Association of Public Health Laboratories is a national non-profit located in Silver Spring, MD, that is dedicated to working with members to strengthen governmental laboratories with a public health mandate. By promoting effective programs and public policy, APHL strives to provide public health laboratories with the resources and infrastructure needed to protect the health of US residents and to prevent and control disease globally.

Click here to see all recent news from this company

WEST HARTFORD, CT–(Marketwire – July 12, 2010) –  ORLive, the vision of improving health, presents a live hip replacement surgery featuring the Continuum Acetabular System and the Fitmore Hip Stem from Zimmer. Earlier in the week ORLive will premiere an update to the Hepatocellular Carcinoma program presented by NewYork-Presbyterian, including information on living donor liver transplant options.

This week ORLive also invites you take part in the latest installment of the Virtual Brain Tumor Board, and to watch and learn from this month’s featured channel of no-visible-scar surgeries.

NEW ON ORLIVE

NEW VIDEO: Program Update: Hepatocellular Carcinoma – Living Donor Liver Transplant

Premieres Tuesday July 13 – In March of this year the Center for Liver Disease and Transplantation of NewYork-Presbyterian presented a special program that highlighted research findings on the diagnosis, treatment and survival rates of Hepatocellular Carcinoma (HCC), from. Now they’re updating this information with new segments on living donor kidney transplant.

HCC, the most common form of liver cancer, is diagnosed in about 24,100 people each year. Watch this webcast to learn more about the latest advances in the diagnosis and treatment of liver cancer.

Viewers will be able to interact and ask questions via the ORLive website. Learn more about this live video broadcast on ORLive.com.

LIVE SURGERY – The Anterior Supine Approach to Total Hip Arthroplasty

Live Wednesday, July 14, 2010, 7PM EDT

ORLive and Zimmer will present a live Total Hip Arthroplasty featuring the Continuum Acetabular System and the Fitmore Hip Stem. The surgery will be performed by Dr. Jonathan Yerasimides, University of Louisville Department of Orthopaedics, Louisville, KY and will be moderated by Dr. Hari Bezwada, University of Pennsylvania School of Medicine Department of Orthopaedic Surgery, Philadelphia, PA. The broadcast will last one hour and will show the entire surgical procedure. This opportunity allows for firsthand insight of the safe and effective implantation and surgical procedure involved with the Continuum Acetabular System and the Fitmore Hip Stem.

Viewers will be able to interact and ask questions via the ORLive website. Learn more about this program, and request a reminder on ORLive.com.

ORLIVE REFERRALS – Week of July 12, 2010

Each week ORLive highlights on-demand videos for our membership and visitors. 

No Visible Scar Surgery Referral: Advances in Laparoscopic Colorectal Surgery: Journey from HALS to NOTES from Covidien

CME Referral: Advances in Pancreatic Cancer Care from Thomas Jefferson University Hospital

Viewer’s Referral: Aortic Aneurysm Repair from Baptist Health Miami

HIGHLIGHTS

NOW ON-DEMAND – German Language Broadcast to Europe, Featuring ConforMIS iUni^® G2 Patient Specific Partial Knee Replacement System

Now Available On-Demand

Originally broadcast live from the University of Wuerzburg Orthopedic Center for Musculoskeletal Research, this video features a partial knee replacement surgery using the ConforMIS iUni G2 system. The broadcast featured Dr. Wolfgang Fitz of Brigham and Women’s Hospital, Dr. Ulrich Nöth and Dr. Maximilian Rudert, both of the University of Wuerzburg Orthopedic Center for Musculoskeletal Research, presenting and performing the surgery. Learn more about this broadcast, presented entirely in German, at http://www.orlive.com/conformis-inc-/videos/n-chste-generation-patienten-spezifischer-knieoberfl-chenersatz-mit-conformis-iuni-sup-/sup-g2-17-00-uhr-mez-1

Viewers are still able to interact and ask questions via the ORLive website. Learn more about this program, and request a reminder on ORLive.com.

NOW ON-DEMAND – Advances in Treating Pediatric Epilepsy

Now Available On-Demand

If a child’s seizures can’t be controlled with medications, surgery may be the solution. See how the Neurosurgical team at NewYork-Presbyterian Phyllis & David Komansky Center for Children’s Health is making advancements in epilepsy. Hosted by Philip Stieg, MD, PhD, and featuring Jeffrey Greenfield, MD, PhD, Samual Weinstein, MD, and Theodore Schwartz, MD, this program goes in depth into the latest surgical advancements and options for patients. 

Viewers of this video are invited to interact with the surgeons via the ORLive website, and to join the community and receive regular updates from the NewYork-Presbyterian Phyllis & David Komansky Center for Children’s Health on pediatric epilepsy.

SUPPLEMENTAL CONTENT – VOX ORLive

Explore robotic assisted mitral valve surgery with cardiac surgeon Dr. Lynn Seto in the current episode of VOX ORLive, an audio podcast featuring the latest advancements in medicine, surgery, and medical technology.

About ORLive

ORLive is the leading provider of video communication channels to the healthcare community. Working collaboratively with hospitals and device manufacturers, ORLive produces and distributes customized, interactive, video programs that demonstrate the latest advances in medicine, surgical techniques and product innovations. The ORLive broadcasting network provides an intimate look at over 650 live and on-demand surgeries to a global audience, streaming over 50,000 hours of programming each month. The ORLive network can be found on-line at www.ORLive.com.

id=”nav_links”>

ALISO VIEJO, CA–(Marketwire – July 12, 2010) –  CNS Response (OTCBB: CNSO) announces the appointment of Michael E. Darkoch as Executive Vice President and Chief Marketing Officer. In this role, Darkoch will assume all responsibility for the launch and commercialization of the Company’s flagship product, Referenced-EEG, including all marketing, business development and patient advocacy activities.

“Mike is a known quantity,” said CNS Response CEO George Carpenter. “In the world of pharmaceutical benefits, he understands what drives consumers, what payers pay for, and how to scale services around them. His industry expertise and payer relationships will be incredibly valuable as we introduce Referenced-EEG to a broader market. I’ve worked with Mike in three companies and his experience, skills and performance record will be crucial to our future success.”

Darkoch joins CNS Response with extensive executive experience at healthcare companies including Baxter International, CORE, Inc, and pharmaceutical benefits management firm Caremark Rx, where he grew sales from $100 million to $2.1 billion within five years, while achieving an industry record of 98 percent client retention for a two-year period. 

Prior to joining CNS Response, Darkoch held senior management positions with MedImpact Health Systems, a prescription benefit management firm in San Diego, where he successfully managed product development and increased new sales revenues 15 percent, market segment revenues by 40 percent and specialty products’ revenues by 35 percent. 

Darkoch commented, “One of the greatest challenges in the pharmaceutical arena is to understand how medications will impact patients differently, and mental disorders represent one of the largest opportunities where numerous medications have individualized outcomes.

“I believe Referenced-EEG may offer an important answer, helping physicians improve clinical outcomes for patients, and economic outcomes for us all. My goal is to establish the CNS Response brand and reputation quickly in this emerging area of personalized medicine.”

Darkoch holds a Bachelor of Science of Industrial Engineering from Lehigh University and Master of Science in Business from Southern Methodist University. He started his engineering and management career with Texas Instruments and Mobil Chemical Company, before moving into the healthcare and pharmaceutical sectors.

About CNS Response
Today, most physicians are able to base treatment on objective test data, such as EKGs, MRIs, blood tests, etc. Broadly speaking, such advances have not yet come to those physicians practicing psychiatry.

Referenced-EEG was developed by physicians to provide objective, personalized, statistical data on patient neurophysiology. In clinical trials, physicians using rEEG data have consistently achieved superior clinical results compared to physicians using trial and error pharmacotherapy.

The Company announced publication last week of results from its most recent clinical trial in The Journal of Psychiatric Research, in which physicians using Referenced-EEG (rEEG^®₎ had success rates reaching 65 percent for patients with treatment-resistant depression.

To read more about the benefits this patented technology provides physicians, patients and insurers, please visit the CNS Response website, www.cnsresponse.com.

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995
Except for the historical information contained herein, the matters discussed are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements involve risks and uncertainties as set forth in the Company’s filings with the Securities and Exchange Commission. These risks and uncertainties could cause actual results to differ materially from any forward-looking statements made herein.

Click here to see all recent news from this company

NEW ORLEANS, LA–(Marketwire – July 12, 2010) –  Hand washing and frequent wiping of surfaces like counters and handrails are necessary elements in institutional infection-control protocols. Effective as these techniques are, however, they are labor intensive, not automated, and do nothing to counter airborne bacteria — one of the primary mechanisms for the spread of disease. With the introduction of Prolitec, Inc.’s aria™ air-sanitizing agent, assisted-living facilities, hospitals, medical offices, and other enclosed spaces finally have a means of addressing this critical gap in infection control.

Prolitec’s Aerobiology and Infection Control division unveiled the new aria™ system today at the annual conference of the Washington, D.C.-based Association for Professionals in Infection Control and Epidemiology, in New Orleans.

The aria™ air-sanitizing system, which won EPA registration in November 2009, uses newly patented Prolitec technology to generate an invisible “dry” vapor of a safe and effective air sanitizing agent. The vapor can be distributed within a space directly from a small wall-mounted appliance or indirectly through an air handler. The result is a uniformly distributed vapor compliant with OSHA air-contaminant restrictions for workplace inhalation — one that is non-damaging to materials and electronics, yet significantly decreases the numbers of viable airborne bacteria under relatively wide conditions of relative humidity and temperature.

“Bacteria and other microorganisms are frequently introduced into the air by actions such as sneezing and coughing. Once microorganisms are airborne they can be inhaled or can settle and contaminate surfaces,” noted Dr. Craig A. Kelly, a veteran Johns Hopkins University scientist and chief of Prolitec’s Aerobiology and Infection-Control unit. “The function of the aria™ system is to reduce the concentration of airborne bacteria in a continuous and automated manner, thereby reducing the likelihood of inhalation or surface-settling of viable microorganisms.”

“An important feature of aria™ is that it is fully automated and works 24 hours a day, seven days a week without any human intervention,” noted Richard Weening, CEO of Milwaukee-based Prolitec. “The aria™ system can safely and effectively reduce background levels of airborne bacteria to establish the foundation of a successful infection-control protocol. It is the one part of the program that will always be 100% compliant.”

Dr. Kelly added: “Amid heightened awareness of disease transmission by airborne microorganisms, aria™ provides a critical tool for the infection-control professional to address airborne bacteria in a way that was not previously available. That can translate into a greater sense of safety and well-being for patients, residents, caregivers and visitors alike.”

About Prolitec
Prolitec (www.prolitec.com) develops and deploys air-treatment and air care technologies, including odor control, ambient scenting, aromatherapy and the use of scent as a medium of communication. Clients include assisted-living facilities, hotels, casinos, retailers and other commercial organizations in the United States and around the world. Prolitec’s Aerobiology and Infection Control Unit is developing interior air and surface systems to inhibit disease transmission.

NOTE TO EDITORS: Photos are available from Parness & Associates

ROCKVILLE, MD–(Marketwire – July 12, 2010) –  MarketResearch.com has announced the addition of GlobalData’s new report “HIV-AIDS – Pipeline Assessment and Market Forecasts to 2016,” to their collection of Diseases & Conditions market reports. For more information, visit http://www.marketresearch.com/product/display.asp?ProductID=2709528.

GlobalData’s report, “HIV/AIDS – Pipeline Assessment and Market Forecasts to 2016” provides an essential source of information and analysis on the global HIV/AIDS market. The report identifies the key trends shaping and driving the global HIV/AIDS market. The report also provides insights on the prevalent competitive landscape and the companies expected to significantly alter the market landscape. Most importantly, the report provides valuable insights on the pipeline products within the global HIV/AIDS sector. GlobalData estimated the HIV/AIDS market was worth $12 billion in 2009. It is forecast to grow at a Compound Annual Growth Rate (CAGR) of 2% for the next seven years to reach $13.7 billion by 2016. The global Human Immunodeficiency Virus (HIV) infection market will continue to grow between 2009 and 2016 at a slower rate due to a series of patent expiries during this period. The growth rate is likely to decline from 2012 onwards due to the impact of the patent expiry of key drugs. The market is characterized by a high unmet need of drugs which can cure the disease. Highly Active Antiretroviral Therapy (HAART) which requires patients to take different classes of drugs has however succeeded in achieving near zero levels of HIV in infected people. Increased uptake of HAART and increasing awareness (which leads to increased treatment seeking) will drive the market. The pipeline for HIV is strong and consists of more than 261 molecules currently in development for various disease segments.

Topics covered in the report include…

• Annualized global HIV/AIDS market revenues data from 2001 to 2009, forecast for seven years to 2016.
• Pipeline analysis data providing a split across phases by mechanism of action, and the emerging trends. The key classes of mechanism of action include HIV vaccines, Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs), Protease Inhibitors (PIs), Multi-class Combination Products, Nucleoside Reverse Transcriptase Inhibitors (NRTIs), CCR5 receptor antagonists, HIV integrase inhibitors, Nucleoside analogues, Viral entry inhibitors, Maturation inhibitors and Fusion Inhibitors.
• Analysis of the current and future market competition in the global HIV/AIDS market. The key market players covered Boehring Ingelheim, Achillion Pharmaceuticals, GlaxoSmithKline, Incyte and Pharmasset, Shire Pharmaceuticals and Tibotec Virco
• Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
• A strategic competitor assessment, market characterization, unmet needs and implications for the future HIV/AIDS market.

For more information visit http://www.marketresearch.com/product/display.asp?ProductID=2709528.

Click here to see all recent news from this company